https://curecurrent.com/trials/the-reach-and-effectiveness-of-technology-enhanced-diabetes-prevention-programs-4001https://curecurrent.com/trials/afrezza-safety-and-pharmacokinetics-study-in-pediatric-patients-4002https://curecurrent.com/trials/reducing-emergency-department-visits-and-improving-glucose-control-in-uncontrolled-type-2-diabetes-using-cgm-sensors-at-4003https://curecurrent.com/trials/islet-transplantation-in-type-1-diabetic-patients-using-the-edmonton-protocol-of-steroid-free-immunosuppression-4004https://curecurrent.com/trials/assessment-of-glycemic-control-in-patients-with-type-2-diabetes-mellitus-and-late-stage-chronic-kidney-disease-4005https://curecurrent.com/trials/relationship-between-insulin-resistance-and-statin-induced-type-2-diabetes-and-integrative-personal-omics-profiling-4006https://curecurrent.com/trials/incretin-effect-in-people-with-impaired-fasting-glucose-4007https://curecurrent.com/trials/a-research-study-to-compare-two-types-of-insulin-insulin-287-and-insulin-glargine-in-people-with-type-2-diabetes-who-hav-4008https://curecurrent.com/trials/impact-of-covid-19-on-marshallese-communities-in-the-u-s-4009https://curecurrent.com/trials/a-research-study-to-compare-insulin-287-once-a-week-to-insulin-glargine-100-units-ml-once-a-day-in-people-with-type-2-di-4010https://curecurrent.com/trials/insulin-tolerance-test-study-in-patients-with-type-1-diabetes-4011https://curecurrent.com/trials/pulsatile-insulin-infusion-therapy-in-patients-with-type-1-and-type-2-diabetes-mellitus-4012https://curecurrent.com/trials/evaluation-of-the-impact-of-intensive-short-term-drug-therapy-in-patients-with-type-2-diabetes-mellitus-4013https://curecurrent.com/trials/clinical-study-to-compare-3-multi-layered-foam-dressings-for-the-management-of-chronic-wounds-4014https://curecurrent.com/trials/multiple-ascending-dose-study-of-hm12460a-in-type-2-diabetes-mellitus-4015https://curecurrent.com/trials/evaluation-of-medtronic-duo-extended-set-4016https://curecurrent.com/trials/renoprotection-in-early-diabetic-nephropathy-in-pima-indians-4017https://curecurrent.com/trials/effects-of-tudca-on-endothelial-function-in-type-2-dm-4018https://curecurrent.com/trials/eliminating-hepatitis-c-virus-4019https://curecurrent.com/trials/feasibility-trial-testing-the-bionic-pancreas-with-zp4207-4020https://curecurrent.com/trials/controlled-insulin-delivery-combining-technology-with-treatment-4021https://curecurrent.com/trials/continuous-glucose-monitoring-management-in-type-2-diabetes-t2d-4022https://curecurrent.com/trials/gestation-diabetes-n-teractive-media-based-education-gdnme-4023https://curecurrent.com/trials/effect-of-sulodexide-in-overt-diabetic-nephropathy-4024https://curecurrent.com/trials/evaluation-of-intra-abdominal-fat-extraction-using-hydrasolve-t2d-in-obese-subjects-with-type-2-diabetes-4025https://curecurrent.com/trials/safety-and-efficacy-of-anti-oxidants-and-anti-inflammatory-agents-in-glaucoma-and-diabetic-retinopathy-4026https://curecurrent.com/trials/initiate-and-maintain-physical-activity-in-clinics-the-impact-diabetes-study-4027https://curecurrent.com/trials/the-effect-of-brown-adipose-tissue-activation-on-insulin-sensitivity-in-humans-4028https://curecurrent.com/trials/pre-diabetes-cardiovascular-cv-care-pre-diabetes-wizard-4029https://curecurrent.com/trials/peru-longitudinal-study-4030https://curecurrent.com/trials/pilot-study-on-the-effects-of-a-plant-strong-diet-on-cardiovascular-risk-factors-4031https://curecurrent.com/trials/glucose-differences-between-the-left-arm-and-right-arm-in-diabetic-patients-using-a-continuous-glucose-monitor-4032https://curecurrent.com/trials/meca-clinical-intervention-meca-health360x-4033https://curecurrent.com/trials/slowly-digestible-carbohydrates-and-the-ileal-brake-4034https://curecurrent.com/trials/hybrid-closed-loop-insulin-delivery-system-in-type-1-diabetes-candidates-for-a-living-donor-kidney-transplant-4035https://curecurrent.com/trials/a-study-of-ly3209590-in-participants-with-type-2-diabetes-mellitus-4036https://curecurrent.com/trials/fit-after-baby-increasing-postpartum-weight-loss-in-women-at-increased-risk-for-cardiometabolic-disease-4037https://curecurrent.com/trials/reliability-of-the-freestyle-libre-cgm-in-the-inpatient-setting-during-the-covid-19-surge-4038https://curecurrent.com/trials/regular-insulin-vs-rapid-insulin-delivered-by-v-go-4039https://curecurrent.com/trials/donepezil-compared-to-placebo-in-patients-with-chronic-neuropathic-pain-4040https://curecurrent.com/trials/impact-of-plasma-soluble-prorenin-receptor-in-obese-and-type-2-diabetic-patients-4041https://curecurrent.com/trials/benefits-of-continuous-glucose-monitoring-with-gem-lifestyle-modification-for-adults-with-type-2-diabetes-4042https://curecurrent.com/trials/study-of-effectiveness-of-liraglutide-added-to-high-dose-insulin-in-type-ii-diabetics-4043https://curecurrent.com/trials/a-study-of-the-analgesic-pain-relief-effects-of-tanezumab-in-adult-patients-with-diabetic-peripheral-neuropathy-4044https://curecurrent.com/trials/basal-insulin-glycemic-control-with-deglugec-vs-aspart-via-pump-4045https://curecurrent.com/trials/enhancing-self-management-support-in-diabetes-through-patient-engagement-4046https://curecurrent.com/trials/preventing-diabetes-with-digital-health-and-coaching-4047https://curecurrent.com/trials/fatty-acid-ethyl-esters-in-meconium-of-infants-of-diabetic-mothers-a-pilot-trial-4048https://curecurrent.com/trials/study-evaluating-retinal-health-monitoring-system-thickness-module-4049https://curecurrent.com/trials/a-psychological-behavioral-intervention-to-increase-activity-in-type-2-diabetes-4050https://curecurrent.com/trials/glucagon-infusion-in-t1d-patients-with-recurrent-severe-hypoglycemia-effects-on-counter-regulatory-responses-4051https://curecurrent.com/trials/comparative-effectiveness-of-cardiovascular-outcomes-in-new-users-of-sglt-2-inhibitors-4052https://curecurrent.com/trials/feasibility-of-using-the-livongo-insulia-study-app-for-patients-with-type-2-diabetes-pilot-study-4053https://curecurrent.com/trials/study-of-akcea-angptl3-lrx-isis-703802-in-participants-with-familial-partial-lipodystrophy-fpl-4054https://curecurrent.com/trials/dapagliflozin-effects-on-epicardial-fat-4055https://curecurrent.com/trials/efficacy-of-solarplast-for-health-and-oxidative-stress-4056https://curecurrent.com/trials/a-study-of-strawberries-and-disease-risk-4057https://curecurrent.com/trials/self-efficacy-beliefs-and-adherence-pilot-and-feasibility-trial-of-a-pharmacist-led-intervention-4058https://curecurrent.com/trials/diabetes-prevention-among-post-partum-women-with-history-of-gestational-diabetes-4059https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pk-and-pd-of-da-1241-in-healthy-male-subjects-and-subjects-with-t2dm-4060https://curecurrent.com/trials/diabetes-and-glycosylation-in-cervical-spondylosis-4061https://curecurrent.com/trials/diabetes-sleep-treatment-trial-for-insomnia-4062https://curecurrent.com/trials/screening-and-risk-factors-of-colon-neoplasia-4063https://curecurrent.com/trials/geography-of-ed-use-and-population-health-4064https://curecurrent.com/trials/diabetes-risk-reduction-through-eat-walk-sleep-and-medication-therapy-management-for-depressed-cambodians-4065https://curecurrent.com/trials/pharmacist-driven-cgm-use-in-the-uninsured-population-4066https://curecurrent.com/trials/freestyle-libre-flash-glucose-monitoring-system-post-approval-study-for-pediatric-patients-4067https://curecurrent.com/trials/culturally-appropriate-strategies-for-chinese-americans-with-diabetes-cascade-4068https://curecurrent.com/trials/quality-initiative-to-improve-glucose-control-in-type-2-diabetic-patients-4069https://curecurrent.com/trials/stories-for-change-digital-storytelling-intervention-for-diabetes-self-management-in-the-covid-19-pandemic-4070https://curecurrent.com/trials/cerebral-responses-to-insulin-induced-hypoglycemia-4071https://curecurrent.com/trials/day-and-night-closed-loop-in-young-people-with-type-1-diabetes-4072https://curecurrent.com/trials/metformin-for-the-prevention-of-the-metabolic-side-effects-of-zyprexa-4073https://curecurrent.com/trials/a-multicenter-double-blind-study-to-evaluate-the-effect-of-pretreatment-with-a-daily-dose-of-sildenafil-on-the-as-needed-4074https://curecurrent.com/trials/study-of-isis-703802-in-participants-with-hypertriglyceridemia-type-2-diabetes-mellitus-and-nonalcoholic-fatty-liver-dis-4075https://curecurrent.com/trials/identifying-the-brain-substrates-of-hypoglycemia-unawareness-in-type-1-diabetes-4076https://curecurrent.com/trials/healthy-body-healthy-souls-in-the-marshallese-population-4077https://curecurrent.com/trials/exenatide-once-weekly-for-smoking-cessation-4078https://curecurrent.com/trials/to-evaluate-the-effect-of-liraglutide-on-ambulatory-blood-pressure-a-pilot-study-4079https://curecurrent.com/trials/study-to-evaluate-the-pharmacokinetics-of-selonsertib-in-participants-with-normal-and-impaired-hepatic-function-4080https://curecurrent.com/trials/connected-pens-for-diabetes-study-4081https://curecurrent.com/trials/primary-care-clinical-excellence-incentive-study-4082https://curecurrent.com/trials/effects-of-curcumin-supplementation-on-gut-barrier-function-in-patients-with-metabolic-syndrome-4083https://curecurrent.com/trials/the-genetics-of-diabetes-in-southern-california-chinese-americans-4084https://curecurrent.com/trials/pregabalin-in-the-treatment-of-pain-due-to-diabetic-peripheral-neuropathy-4085https://curecurrent.com/trials/development-of-agents-to-diminish-the-risk-of-hypoglycemia-induced-brain-injury-in-type-1-diabetes-4086https://curecurrent.com/trials/intraoperative-dexamethasone-and-its-effect-on-hyperglycemia-4087https://curecurrent.com/trials/exploratory-study-of-the-efficacy-of-standard-of-care-revascularization-of-the-lower-extremity-4088https://curecurrent.com/trials/a-study-comparing-ly900014-to-insulin-lispro-humalog-in-adults-with-type-1-diabetes-using-insulin-pump-therapy-4089https://curecurrent.com/trials/coaching-and-education-for-diabetes-distress-4090https://curecurrent.com/trials/a-randomized-study-to-evaluate-the-efficacy-of-insulclock-in-patients-with-uncontrolled-type-2-diabetes-4091https://curecurrent.com/trials/pregabalin-vs-placebo-in-treatment-of-neuropathic-pain-associated-with-diabetic-peripheral-neuropathy-4092https://curecurrent.com/trials/a-study-of-ly3437943-in-participants-with-type-2-diabetes-mellitus-t2dm-4093https://curecurrent.com/trials/study-of-pregabalin-lyrica-in-patients-with-painful-diabetic-peripheral-neuropathy-4094https://curecurrent.com/trials/morning-light-treatment-to-improve-glucose-metabolism-4095https://curecurrent.com/trials/levels-of-serum-resistin-in-asthmatics-as-a-potential-marker-of-systemic-inflammation-and-disease-state-4096https://curecurrent.com/trials/a-reinforcement-approach-to-improve-diabetes-management-4097https://curecurrent.com/trials/multiple-dose-trial-examining-dose-range-escalation-and-efficacy-of-oral-semaglutide-in-subjects-with-type-2-diabetes-4098https://curecurrent.com/trials/a-trial-to-investigate-hyperglycemic-and-hypoglycemic-excursions-in-subjects-with-type-1-diabetes-4099https://curecurrent.com/trials/multiple-applications-of-expressgraft-c9t1-skin-tissue-as-a-treatment-for-diabetic-foot-ulcers-4100https://curecurrent.com/trials/lifestyle-intervention-for-senior-diabetics-4101https://curecurrent.com/trials/a-research-study-to-compare-the-effect-of-insulin-degludec-and-insulin-glargine-on-blood-sugar-levels-in-people-with-typ-4102https://curecurrent.com/trials/the-vrif-trial-hypoglycemia-reduction-with-automated-insulin-delivery-system-4103https://curecurrent.com/trials/mindfulness-training-and-group-counseling-among-prediabetes-and-diabetes-patients-4104https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-sequential-single-and-multiple-ascending-doses-of-yg1699-4105https://curecurrent.com/trials/safety-and-efficacy-of-clbs03-in-adolescents-with-recent-onset-type-1-diabetes-the-sanford-project-t-rex-study-4106https://curecurrent.com/trials/comparison-of-insulins-aspart-and-lispro-in-insulin-pumps-4107https://curecurrent.com/trials/a-study-of-an-insulin-management-system-in-participants-with-type-1-or-type-2-diabetes-4108https://curecurrent.com/trials/almond-consumption-and-glycemia-4109https://curecurrent.com/trials/coronary-flow-reserve-to-assess-cardiovascular-inflammation-cirt-cfr-4110https://curecurrent.com/trials/piloting-diet-and-exercise-interventions-in-older-hispanics-with-diabetes-4111https://curecurrent.com/trials/a-study-to-evaluate-the-safety-pharmacokinetics-pk-and-pharmacodynamics-pd-for-tak-906-in-participants-with-diabetes-mel-4112https://curecurrent.com/trials/effect-of-lik066-on-body-weight-in-patients-with-elevated-body-mass-index-4113https://curecurrent.com/trials/safety-and-efficacy-of-chlorthalidone-in-type-1-diabetes-4114https://curecurrent.com/trials/treatment-of-neuropathic-pain-associated-with-diabetic-peripheral-neuropathy-4115https://curecurrent.com/trials/safety-pharmacokinetics-and-efficacy-of-bimagrumab-in-overweight-and-obese-patients-with-type-2-diabetes-4116https://curecurrent.com/trials/valued-epigenetic-glycemic-improvements-through-weight-loss-4117https://curecurrent.com/trials/effect-cinnamon-spice-on-postprandial-glucose-and-insulin-responses-4118https://curecurrent.com/trials/mental-health-screenings-in-adolescents-with-type-i-diabetes-4119https://curecurrent.com/trials/transition-of-diabetes-care-from-pediatric-to-adult-healthcare-providers-4120https://curecurrent.com/trials/dietary-protein-and-insulin-sensitivity-study-4121https://curecurrent.com/trials/effect-of-blueberry-consumption-on-metabolic-syndrome-dna-damage-4122https://curecurrent.com/trials/intervention-to-promote-weight-loss-in-latinas-at-risk-for-diabetes-4123https://curecurrent.com/trials/combined-antibody-screening-for-celiac-and-diabetes-evaluation-4124https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-pk-and-pharmacodynamics-pd-assessment-of-lik066-in-healthy-subjects-and-in-patients-4125https://curecurrent.com/trials/efficacy-of-fixed-combination-therapy-of-vildagliptin-and-metformin-compared-to-the-individual-monotherapy-components-in-4126https://curecurrent.com/trials/efficacy-and-safety-of-fixed-combination-therapy-of-vildagliptin-and-metformin-25-1000-mg-bid-in-patients-with-type-2-di-4127https://curecurrent.com/trials/trial-of-diet-in-gestational-diabetes-mellitus-metabolic-consequences-to-mother-and-offspring-4128https://curecurrent.com/trials/a-sub-study-to-lmf237a2302-to-assess-the-effect-of-24-weeks-treatment-with-initial-combination-of-vildagliptin-plus-metf-4129https://curecurrent.com/trials/safety-and-tolerability-of-vildagliptin-versus-sitagliptin-in-patients-with-type-2-diabetes-and-severe-renal-insufficien-4130https://curecurrent.com/trials/vildagliptin-compared-to-glimepiride-in-combination-with-metformin-in-patients-with-type-2-diabetes-4131https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-in-combination-with-pioglitazone-in-patients-with-type-2-diabetes-4132https://curecurrent.com/trials/assessment-of-the-skin-concentration-of-vildagliptin-50-mg-every-12-hours-for-10-days-in-healthy-subjects-and-patients-w-4133https://curecurrent.com/trials/safety-and-tolerability-of-vildagliptin-versus-sitagliptin-in-patients-with-type-2-diabetes-and-severe-renal-insufficien-4134https://curecurrent.com/trials/efficacy-and-long-term-safety-of-vildagliptin-as-monotherapy-in-patients-with-type-2-diabetes-4135https://curecurrent.com/trials/efficacy-safety-of-vildagliptin-and-metformin-combination-therapy-in-patients-with-type-2-diabetes-not-well-controlled-w-4136https://curecurrent.com/trials/clinical-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-lez763-4137https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-ocriplasmin-in-inducing-total-pvd-in-subjects-with-npdr-4138https://curecurrent.com/trials/assessment-of-quality-of-life-and-satisfaction-with-medical-care-of-pediatric-type-1-diabetes-mellitus-patients-4139https://curecurrent.com/trials/diabetes-prevention-program-lifestyle-intervention-in-the-marshallese-population-4140https://curecurrent.com/trials/identification-and-treatment-of-diabetes-in-solid-organ-transplant-recipients-4141https://curecurrent.com/trials/diabetes-autoimmunity-withdrawn-in-new-onset-patients-dawn-4142https://curecurrent.com/trials/rural-engagement-in-primary-care-for-optimizing-weight-reduction-4143https://curecurrent.com/trials/effect-of-protein-intake-on-post-prandial-hyperglycemia-in-children-and-adolescents-with-type1-diabetes-mellitus-4144https://curecurrent.com/trials/glitazone-treatment-for-coronavirus-hypoxia-a-safety-and-tolerability-open-label-with-matching-cohort-pilot-study-4145https://curecurrent.com/trials/a-multicenter-clinical-trial-of-allopurinol-to-prevent-kidney-function-loss-in-type-1-diabetes-4146https://curecurrent.com/trials/effects-of-bkr-017-on-insulin-resistance-in-type-2-diabetes-patients-4147https://curecurrent.com/trials/safety-trial-of-the-reddress-wound-care-system-rd1-in-management-of-texas-1a-or-2a-neuropathic-diabetic-foot-ulcers-4148https://curecurrent.com/trials/assess-screening-for-diabetic-retinopathy-using-retinal-camera-in-family-medicine-clinic-4149https://curecurrent.com/trials/artificial-pancreas-with-different-stress-assessments-in-the-outpatient-setting-4150https://curecurrent.com/trials/safety-and-efficacy-of-exenatide-as-monotherapy-and-adjunctive-therapy-to-oral-antidiabetic-agents-in-adolescents-with-t-4151https://curecurrent.com/trials/evaluation-of-the-safety-and-effectiveness-of-the-dexcom-glucose-monitoring-cgm-system-4152https://curecurrent.com/trials/home-sleep-and-circadian-phase-mediators-of-diabetes-risk-4153https://curecurrent.com/trials/safety-and-efficacy-of-albiglutide-insulin-glargine-versus-insulin-lispro-insulin-glargine-subjects-with-type-2-diabetes-4154https://curecurrent.com/trials/carvedilol-in-treating-hypoglycemia-unawareness-4155https://curecurrent.com/trials/the-efficacy-and-safety-of-faster-insulin-aspart-fiasp-compared-to-conventional-insulin-aspart-novolog-as-correction-bol-4156https://curecurrent.com/trials/postprandial-response-to-almond-consumption-in-overweight-hispanic-pregnant-women-4157https://curecurrent.com/trials/zinc-and-diabetes-in-patients-with-thalassemia-a-pilot-study-4158https://curecurrent.com/trials/spontaneous-coronary-artery-dissection-scad-and-autoimmunity-4159https://curecurrent.com/trials/metabolic-parameters-3-months-9-months-and-2-years-after-bariatric-surgery-4160https://curecurrent.com/trials/food-order-intervention-for-gestational-diabetes-4161https://curecurrent.com/trials/carat-canagliflozin-vs-placebo-for-post-bariatric-patients-with-persistent-type-2-diabetes-4162https://curecurrent.com/trials/breast-milk-and-infant-growth-among-lean-overweight-and-diabetic-mothers-4163https://curecurrent.com/trials/dario-blood-glucose-monitoring-system-android-devices-altitude-evaluation-study-4164https://curecurrent.com/trials/healthy-diet-for-healthy-moms-and-babies-4165https://curecurrent.com/trials/let-s-empower-and-prepare-young-adults-with-type-1-diabetes-4166https://curecurrent.com/trials/freestyle-libre-continuous-glucose-monitoring-system-accuracy-study-4167https://curecurrent.com/trials/a-dose-finding-study-of-ro4998452-in-patients-with-diabetes-mellitus-4168https://curecurrent.com/trials/lira-add2sglt2i-liraglutide-versus-placebo-as-add-on-to-sglt2-inhibitors-4169https://curecurrent.com/trials/evaluate-tolerability-of-myfortic-simulect-and-tacrolimus-without-steroids-in-three-patient-populations-4170https://curecurrent.com/trials/diabetes-to-go-inpatient-education-implementation-4171https://curecurrent.com/trials/arsenic-disordered-glucose-homeostasis-and-atherosclerosis-4172https://curecurrent.com/trials/clinical-trial-of-zocor-simvastatin-and-vytorin-ezetimibe-simvastatin-in-adolescents-with-type-1-diabetes-4173https://curecurrent.com/trials/stepping-down-approach-in-patients-with-chronic-poorly-controlled-diabetes-on-advanced-insulin-therapy-4174https://curecurrent.com/trials/sugar-challenge-study-4175https://curecurrent.com/trials/transition-preparation-intervention-for-young-adults-with-type-1-diabetes-4176https://curecurrent.com/trials/pediatric-longitudinal-cohort-study-of-chronic-pancreatitis-4177https://curecurrent.com/trials/diabetic-foot-ulcer-and-wound-infection-4178https://curecurrent.com/trials/developing-a-diabetic-foot-ulcer-protocol-4179https://curecurrent.com/trials/hyperglycemia-in-renal-transplantation-4180https://curecurrent.com/trials/effect-of-dietary-habits-on-metabolic-health-4181https://curecurrent.com/trials/dhacm-vs-other-commercially-available-treatments-4182https://curecurrent.com/trials/a-pragmatic-approach-to-lowering-the-risk-of-diabetes-mellitus-after-a-diagnosis-of-gestational-diabetes-mellitus-4183https://curecurrent.com/trials/safety-and-efficacy-of-ranibizumab-for-diabetic-macular-edema-4184https://curecurrent.com/trials/mobile-health-behavioral-intervention-in-patients-with-heart-failure-and-diabetes-mellitus-4185https://curecurrent.com/trials/plasma-tmao-and-choline-levels-in-individuals-with-metabolic-syndrome-comparison-between-eggs-and-choline-supplement-4186https://curecurrent.com/trials/metabolomic-profiling-in-adolescents-with-obesity-and-diabetes-4187https://curecurrent.com/trials/study-evaluating-safety-tolerability-and-action-of-oap-189-in-subjects-with-type-2-diabetes-on-metformin-4188https://curecurrent.com/trials/ziprasidone-for-improving-insulin-sensitivity-in-people-with-schizophrenia-who-are-at-risk-for-diabetes-4189https://curecurrent.com/trials/a-study-comparing-the-effect-of-albiglutide-with-exenatide-on-regional-brain-activity-related-to-nausea-in-healthy-subje-4190https://curecurrent.com/trials/an-exploratory-study-on-the-effects-of-repeat-doses-of-albiglutide-compared-to-exenatide-on-gastric-myoelectrical-activi-4191https://curecurrent.com/trials/improving-medication-adherence-in-the-alabama-black-belt-4192https://curecurrent.com/trials/a-study-of-ly900014-in-a-medtronic-pump-4193https://curecurrent.com/trials/nitrite-infusion-in-islet-cell-transplantation-4194https://curecurrent.com/trials/glucose-control-using-1-5-ag-testing-4195https://curecurrent.com/trials/metformin-gastrointestinal-intolerance-measurement-of-mitochondrial-complex-i-4196https://curecurrent.com/trials/living-hungry-healthy-foods-prescription-program-4197https://curecurrent.com/trials/bionic-pancreas-in-children-with-hyperinsulinism-and-post-pancreatectomy-diabetes-4198https://curecurrent.com/trials/pilot-insulin-sensitivity-management-in-hyperglycemic-patients-in-perioperative-period-esrd-non-esrd-4199https://curecurrent.com/trials/can-vitamin-d3-improve-cognitive-function-in-individuals-with-type-2-diabetes-think-d-4200https://curecurrent.com/trials/combining-flash-glucose-monitoring-and-online-peer-support-to-improve-outcomes-in-hispanics-with-type-2-diabetes-4201https://curecurrent.com/trials/the-fruit-and-vegetable-prescription-program-study-4202https://curecurrent.com/trials/type-1-diabetes-and-the-brain-in-children-4203https://curecurrent.com/trials/dapagliflozin-and-measures-of-cardiovascular-autonomic-function-in-patients-with-type-2-diabetes-t2d-4204https://curecurrent.com/trials/inpatient-closed-loop-glucose-control-with-the-gen-2-glucostat-4205https://curecurrent.com/trials/safety-study-of-using-symlin-alongside-insulin-in-a-multiple-injection-port-4206https://curecurrent.com/trials/the-s-l-i-m-m-s-procedure-for-severe-clinical-obesity-4207https://curecurrent.com/trials/using-an-mhealth-app-to-transition-care-of-type-1-diabetes-from-parents-to-teens-4208https://curecurrent.com/trials/metformin-to-augment-low-milk-supply-malms-study-4209https://curecurrent.com/trials/the-effect-of-lysulin-on-glycemic-control-and-advanced-glycation-4210https://curecurrent.com/trials/readmission-prevention-pilot-trial-in-diabetes-patients-4211https://curecurrent.com/trials/effect-of-2-week-nightly-moderate-hypoxia-on-glucose-tolerance-in-individuals-with-type-2-diabetes-4212https://curecurrent.com/trials/glyburide-vs-glucovance-in-the-treatment-of-gdm-4213https://curecurrent.com/trials/improving-diabetes-medication-adherence-for-african-americans-in-madison-and-milwaukee-through-peer-support-4214https://curecurrent.com/trials/thermal-screening-for-early-diabetic-peripheral-neuropathy-dpn-4215https://curecurrent.com/trials/bone-health-in-youth-with-type-1-diabetes-4216https://curecurrent.com/trials/natural-history-of-autoimmune-diabetes-and-its-complications-4217https://curecurrent.com/trials/pancreatic-islet-transplantation-into-the-gastric-submucosa-4218https://curecurrent.com/trials/evaluate-the-safety-and-efficacy-of-regenkit-autologous-prp-gel-for-the-treatment-of-diabetic-foot-ulcer-4219https://curecurrent.com/trials/study-of-a-carbohydrate-drink-in-adults-4220https://curecurrent.com/trials/a-safety-study-of-arry-403-in-patients-with-type-2-diabetes-4221https://curecurrent.com/trials/effect-of-dry-roasted-peanuts-and-boiled-peanuts-on-glycemic-control-4222https://curecurrent.com/trials/stop-emergency-room-visits-for-hyperglycemia-project-district-of-columbia-dc-4223https://curecurrent.com/trials/treatment-of-type-2-diabetes-with-immunonutrients-4224https://curecurrent.com/trials/study-of-a-holistic-health-program-for-united-methodist-clergy-4225https://curecurrent.com/trials/fiasp-vs-novolog-in-type-1-diabetics-using-670g-medtronic-pump-4226https://curecurrent.com/trials/the-mhero-study-michigan-s-hypertension-diabetes-and-obesity-education-research-online-4227https://curecurrent.com/trials/genomics-and-epigenomics-for-new-insights-in-female-oab-genie-study-4228https://curecurrent.com/trials/prediction-of-findings-from-the-ongoing-carolina-trial-using-healthcare-database-analyses-4229https://curecurrent.com/trials/multicenter-study-to-evaluate-the-effect-of-bti320-on-glycemic-control-in-type-2-diabetes-4230https://curecurrent.com/trials/strengths-based-behavioral-mhealth-app-for-parents-of-adolescents-with-type-1-diabetes-pilot-study-4231https://curecurrent.com/trials/healthy-living-partnerships-to-prevent-diabetes-in-veterans-pilot-study-4232https://curecurrent.com/trials/medstar-health-type-2-diabetes-pathway-to-control-4233https://curecurrent.com/trials/early-administration-of-long-acting-insulin-treatment-of-diabetic-ketoacidosis-in-pediatric-type-1-diabetes-4234https://curecurrent.com/trials/adaptive-optics-for-ophthalmic-technologies-4235https://curecurrent.com/trials/a-nutritarian-study-to-evaluate-the-effectiveness-of-lifestyle-changes-in-chronic-disease-prevention-especially-cancer-4236https://curecurrent.com/trials/validation-of-machine-learning-based-personalized-nutrition-algorithm-to-reduce-postprandial-glycemic-excursions-among-n-4237https://curecurrent.com/trials/monitored-home-exercise-in-pregnancy-4238https://curecurrent.com/trials/sglt2-inhibition-and-stimulation-of-endogenous-glucose-production-protocol-2-4239https://curecurrent.com/trials/protocol-3-role-of-the-renal-nerves-in-the-increase-in-egp-in-response-to-glucosuria-4240https://curecurrent.com/trials/prominent-eye-ancillary-study-protocol-ad-4241https://curecurrent.com/trials/healthsnap-on-epicardial-adipose-tissue-study-4242https://curecurrent.com/trials/personal-activity-intelligence-pai-pilot-4243https://curecurrent.com/trials/feasibility-study-of-new-subcutaneous-glucose-sensor-with-recording-devices-4244https://curecurrent.com/trials/wellstart-reboot-study-4245https://curecurrent.com/trials/supporting-treatment-adherence-needs-in-diabetes-4246https://curecurrent.com/trials/use-of-nph-versus-basal-bolus-insulin-for-steroid-induced-hyperglycemia-4247https://curecurrent.com/trials/a-pilot-study-metformin-therapy-in-heart-failure-patients-with-early-diabetes-or-at-high-risk-of-developing-diabetes-pre-4248https://curecurrent.com/trials/endocrinology-auto-triggered-e-consults-4249https://curecurrent.com/trials/new-glucose-sensor-pediatric-4250https://curecurrent.com/trials/women-in-control-a-virtual-world-study-of-diabetes-self-management-4251https://curecurrent.com/trials/management-of-diabetes-with-metformin-in-patients-with-chronic-heart-failure-4252https://curecurrent.com/trials/evaluating-the-use-of-exenatide-in-people-with-type-2-diabetes-and-diastolic-heart-failure-4253https://curecurrent.com/trials/msi-78-topical-cream-vs-oral-ofloxacin-in-the-treatment-of-infected-diabetic-ulcers-4254https://curecurrent.com/trials/patient-empowerment-study-4255https://curecurrent.com/trials/a-placebo-controlled-randomized-double-blind-trial-of-milnacipran-for-the-treatment-of-idiopathic-neuropathy-pain-4256https://curecurrent.com/trials/msi-78-topical-cream-vs-oral-ofloxacin-in-the-treatment-of-infected-diabetic-ulcers-4257https://curecurrent.com/trials/peer-support-dyads-in-churches-4258https://curecurrent.com/trials/walnuts-to-achieve-lasting-nutrition-to-prevent-diabetes-4259https://curecurrent.com/trials/a-comprehensive-intervention-for-diabetes-and-comorbid-depression-in-primary-care-4260https://curecurrent.com/trials/shared-health-appointments-and-reciprocal-enhanced-support-4261https://curecurrent.com/trials/improving-physical-activity-through-a-mhealth-intervention-in-cardio-metabolic-risk-patients-4262https://curecurrent.com/trials/text-to-move-ttm-study-4263https://curecurrent.com/trials/approaches-to-foot-complication-prevention-a-survey-of-diabetes-educators-4264https://curecurrent.com/trials/a-reinforcement-approach-to-increase-use-of-cgm-4265https://curecurrent.com/trials/trial-of-iw-1973-a-stimulator-of-soluble-guanylate-cyclase-sgc-in-patients-with-stable-type-2-diabetes-and-hypertension-4266https://curecurrent.com/trials/therapeutic-stockings-to-prevent-foot-ulcers-4267https://curecurrent.com/trials/feasibility-and-impact-of-abcs-of-diabetes-self-management-education-program-at-an-urban-public-library-4268https://curecurrent.com/trials/single-and-multiple-ascending-doses-of-medi6570-in-subjects-with-type-2-diabetes-mellitus-4269https://curecurrent.com/trials/propranolol-in-treating-hypoglycemia-unawareness-4270https://curecurrent.com/trials/instant-total-contact-cast-to-heal-diabetic-foot-ulcers-4271https://curecurrent.com/trials/a-study-of-technology-to-improve-glucose-control-in-participants-with-type-1-diabetes-4272https://curecurrent.com/trials/improving-medication-adherence-among-underserved-patients-with-type-2-diabetes-4273https://curecurrent.com/trials/fat-cell-size-in-insulin-resistance-4274https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-medi0382-in-the-treatment-of-overweight-and-obese-subjects-with-type-2-di-4275https://curecurrent.com/trials/high-intensity-body-weight-circuit-training-in-type-2-diabetics-4276https://curecurrent.com/trials/electrical-stimulation-for-improving-balance-in-diabetes-4277https://curecurrent.com/trials/intestinal-sweet-taste-receptor-function-and-adaptation-to-dietary-sugars-and-sweeteners-4278https://curecurrent.com/trials/the-loop-observational-study-4279https://curecurrent.com/trials/effect-of-dietary-glycemic-index-on-beta-cell-function-4280https://curecurrent.com/trials/novel-offloading-for-diabetic-foot-ulcers-with-pulseflow-a-prospective-study-4281https://curecurrent.com/trials/a-clinical-trial-comparing-glycaemic-control-and-safety-of-insulin-degludec-liraglutide-ideglira-versus-insulin-glargine-4282https://curecurrent.com/trials/dextenza-vs-prednisolone-acetate-1-macular-edema-with-diabetic-retinopathy-after-cataract-surgery-4283https://curecurrent.com/trials/examining-the-effects-of-antipsychotic-medications-on-insulin-sensitivity-4284https://curecurrent.com/trials/prevention-of-diabetes-progression-trial-pdpt-4285https://curecurrent.com/trials/improving-medication-adherence-in-older-african-americans-with-diabetes-4286https://curecurrent.com/trials/pasos-improving-the-health-of-immigrant-workers-4287https://curecurrent.com/trials/cgm-use-in-islet-transplant-recipients-4288https://curecurrent.com/trials/enhancing-mhealth-technology-to-activate-chronic-care-patients-4289https://curecurrent.com/trials/teplizumab-for-prevention-of-type-1-diabetes-in-relatives-at-risk-4290https://curecurrent.com/trials/laser-vs-bevacizumab-injection-alone-in-treatment-of-diabetic-macular-edema-4291https://curecurrent.com/trials/social-incentives-to-increase-mobility-4292https://curecurrent.com/trials/islet-transplant-in-patients-with-type-i-diabetes-4293https://curecurrent.com/trials/studying-the-effectiveness-of-non-invasive-glucose-sensors-in-patients-with-diabetes-the-sensor-study-4294https://curecurrent.com/trials/epidermal-adhesive-sensors-to-enhance-continuous-glucose-measurement-in-patients-with-diabetes-the-ease-study-4295https://curecurrent.com/trials/evaluating-the-effects-of-kombucha-as-a-hyperglycemic-therapeutic-agent-within-diabetic-human-subjects-4296https://curecurrent.com/trials/effect-of-diabetes-mellitus-on-cholesterol-metabolism-4297https://curecurrent.com/trials/pediatric-preventative-health-screenings-obesity-and-family-centered-outcomes-4298https://curecurrent.com/trials/translating-telephonic-diabetes-self-management-support-to-primary-care-practice-4299https://curecurrent.com/trials/risk-factor-control-before-orthopedic-surgery-4300https://curecurrent.com/trials/immune-effects-of-oral-insulin-in-relatives-at-risk-for-type-1-diabetes-mellitus-tn20-4301https://curecurrent.com/trials/cardiovascular-inflammation-reduction-trial-4302https://curecurrent.com/trials/comparison-of-insulin-alone-to-insulin-with-metformin-to-treat-gestational-diabetes-mellitus-4303https://curecurrent.com/trials/pilot-of-home-visitation-services-for-patients-with-a-diabetes-diagnosis-4304https://curecurrent.com/trials/education-and-exercise-program-for-adults-with-type-2-diabetes-4305https://curecurrent.com/trials/prevention-through-intervention-telehealth-solution-to-deter-911-calls-due-to-hypoglycemia-4306https://curecurrent.com/trials/pilot-prospective-cgm-quality-improvement-qi-project-in-pregnancy-4307https://curecurrent.com/trials/effect-of-gelesis200-on-body-weight-in-overweight-and-obese-subjects-w-o-type-2-diabetes-4308https://curecurrent.com/trials/a-study-of-once-daily-nnc0090-2746-in-participants-with-type-2-diabetes-inadequately-controlled-with-metformin-4309https://curecurrent.com/trials/strong-people-strength-training-study-4310https://curecurrent.com/trials/comparison-of-two-screening-strategies-for-gestational-diabetes-gdm2-4311https://curecurrent.com/trials/amnioexcel-plus-vs-a-marketed-comparator-vs-soc-in-the-management-of-diabetic-foot-ulcers-4312https://curecurrent.com/trials/red-raspberry-polyphenols-on-gut-microbiome-4313https://curecurrent.com/trials/lifestyle-management-of-ckd-in-obese-diabetic-patients-4314https://curecurrent.com/trials/acr-lab-urine-analysis-test-system-evaluation-of-performance-4315https://curecurrent.com/trials/a-crowdsourced-social-media-portal-for-parents-of-very-young-children-with-type-1-diabetes-4316https://curecurrent.com/trials/measuring-sweat-glucose-of-patients-with-diabetes-the-engage-study-4317https://curecurrent.com/trials/cardiovascular-outcomes-and-hba1c-among-patients-with-type-2-diabetes-newly-initiating-glp1ras-vs-basal-insulin-4318https://curecurrent.com/trials/non-alcoholic-fatty-liver-disease-and-coronary-heart-disease-in-type-2-diabetes-patients-4319https://curecurrent.com/trials/multicenter-study-to-evaluate-the-efficacy-and-safety-of-metoclopramide-nasal-spray-in-men-with-diabetic-gastroparesis-4320https://curecurrent.com/trials/physical-activity-and-glycemic-control-in-adolescents-4321https://curecurrent.com/trials/efficacy-in-controlling-glycaemia-with-victoza-liraglutide-as-add-on-to-metformin-vs-oads-as-add-on-to-metformin-after-u-4322https://curecurrent.com/trials/episodic-to-real-time-care-in-diabetes-self-management-4323https://curecurrent.com/trials/prospective-study-of-adjunctive-carotenoids-plus-anti-oxidants-in-anti-vegf-treated-diabetic-macular-edema-4324https://curecurrent.com/trials/4-week-multiple-dose-dose-escalating-study-in-patients-with-type-2-diabetes-4325https://curecurrent.com/trials/role-of-glucagon-in-glucose-control-in-cystic-fibrosis-related-diabetes-4326https://curecurrent.com/trials/empagliflozin-in-heart-failure-diuretic-and-cardio-renal-effects-4327https://curecurrent.com/trials/a-52-week-international-multicenter-trial-with-a-long-term-extension-to-evaluate-saxagliptin-with-dapagliflozin-in-combi-4328https://curecurrent.com/trials/early-gestational-diabetes-screening-in-the-gravid-obese-woman-4329https://curecurrent.com/trials/tocilizumab-for-the-treatment-of-cytokine-release-syndrome-in-patients-with-covid-19-sars-cov-2-infection-4330https://curecurrent.com/trials/a-study-of-dulaglutide-ly2189265-in-participants-with-type-2-diabetes-mellitus-4331https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-dulaglutide-ly2189265-in-participants-with-type-2-diabetes-4332https://curecurrent.com/trials/research-study-to-look-at-fast-acting-insulin-aspart-with-the-insulin-pump-system-ilet-in-adults-with-type-1-diabetes-4333https://curecurrent.com/trials/ot-led-interdisciplinary-diabetes-self-management-prgm-4334https://curecurrent.com/trials/efficacy-and-safety-of-nyx-2925-in-subjects-with-neuropathic-pain-associated-with-diabetic-peripheral-neuropathy-4335https://curecurrent.com/trials/study-title-food-rx-4336https://curecurrent.com/trials/cs02-vs-placebo-with-metformin-in-type-2-diabetes-mellitus-t2dm-4337https://curecurrent.com/trials/effect-of-liraglutide-victoza-on-inflammation-in-human-adipose-tissue-and-blood-4338https://curecurrent.com/trials/project-nightlight-efficacy-and-system-acceptance-of-dinner-night-vs-24hr-closed-loop-control-4339https://curecurrent.com/trials/influenza-vaccination-digital-interventions-for-people-living-with-diabetes-4340https://curecurrent.com/trials/vitamin-d-cardiovascular-disease-and-african-americans-4341https://curecurrent.com/trials/redox-imbalance-and-the-development-of-cystic-fibrosis-diabetes-4342https://curecurrent.com/trials/study-of-the-reversibility-of-glucose-intolerance-caused-by-chronic-aspartame-consumption-4343https://curecurrent.com/trials/cgm-reimagine-primary-care-4344https://curecurrent.com/trials/safety-study-of-mesenchymal-precursor-cells-in-type-2-diabetes-4345https://curecurrent.com/trials/fih-ph-1-study-of-trpc5-channel-inhibitor-gfb-887-in-healthy-subjects-4346https://curecurrent.com/trials/non-exercise-physical-activity-intervention-4347https://curecurrent.com/trials/a-study-of-granexin-gel-in-the-treatment-of-diabetic-foot-ulcer-4348https://curecurrent.com/trials/descriptive-analysis-of-near-infrared-spectroscopy-in-critically-ill-and-injured-pediatric-and-neonatal-patients-4349https://curecurrent.com/trials/a-study-in-ckd-patients-with-type-2-diabetes-mellitus-and-albuminuria-4350https://curecurrent.com/trials/prevention-of-macular-edema-in-patients-with-diabetic-retinopathy-undergoing-cataract-surgery-4351https://curecurrent.com/trials/g-pen-compared-to-glucagen-hypokit-for-severe-hypoglycemia-rescue-in-adults-with-type-1-diabetes-4352https://curecurrent.com/trials/an-administration-method-study-of-human-regular-u-500-insulin-ly041001-in-participants-with-type-2-diabetes-mellitus-4353https://curecurrent.com/trials/folfirinox-followed-by-ipilimumab-with-pancreatic-tumor-vaccine-in-treatment-of-metastatic-pancreatic-cancer-4354https://curecurrent.com/trials/a-psychological-behavioral-intervention-for-physical-activity-in-type-2-diabetes-4355https://curecurrent.com/trials/comparative-user-experiences-with-bd-nano-pro-32g-extra-thin-wall-pen-needle-vs-the-terumo-nanopass-34g-pen-needle-4356https://curecurrent.com/trials/activity-for-diabetic-polyneuropathy-4357https://curecurrent.com/trials/feeding-america-intervention-trial-for-health-diabetes-mellitus-4358https://curecurrent.com/trials/comprehensive-informatics-framework-for-comparative-effectiveness-research-cer-dissemination-4359https://curecurrent.com/trials/effects-of-a-remote-patient-monitoring-protocol-on-glycemic-control-in-adolescents-with-type-1-diabetes-4360https://curecurrent.com/trials/bewell24-smartphone-based-diabetes-prevention-in-the-va-4361https://curecurrent.com/trials/effects-of-recombinant-human-glutamic-acid-decarboxylase-on-the-progression-of-type-1-diabetes-in-new-onset-subjects-4362https://curecurrent.com/trials/oral-insulin-for-prevention-of-diabetes-in-relatives-at-risk-for-type-1-diabetes-mellitus-4363https://curecurrent.com/trials/glargine-u300-hospital-trial-4364https://curecurrent.com/trials/intravenous-ctla4-lg-treatment-in-recent-onset-type-1-diabetes-mellitus-4365https://curecurrent.com/trials/rituximab-in-new-onset-type-1-diabetes-4366https://curecurrent.com/trials/canakinumab-study-in-individuals-with-newly-diagnosed-type-1-diabetes-4367https://curecurrent.com/trials/prevention-of-autoimmune-destruction-and-rejection-of-human-pancreatic-islets-following-transplantation-for-insulin-depe-4368https://curecurrent.com/trials/new-onset-of-type-1-diabetes-mycophenolate-mofetil-daclizumab-clinical-trial-4369https://curecurrent.com/trials/taking-action-a-care-for-type-2-diabetes-intervention-for-couples-4370https://curecurrent.com/trials/a-study-of-ly900014-in-participants-with-type-1-diabetes-4371https://curecurrent.com/trials/middle-school-based-primary-prevention-trial-of-type-2-diabetes-4372https://curecurrent.com/trials/nutritional-intervention-to-prevent-diabetes-4373https://curecurrent.com/trials/study-of-a-postpartum-diabetes-prevention-program-for-hispanic-women-4374https://curecurrent.com/trials/validation-of-a-novel-screening-test-for-maternal-insulin-resistance-4375https://curecurrent.com/trials/the-international-diabetes-closed-loop-idcl-trial-clinical-acceptance-of-the-artificial-pancreas-4376https://curecurrent.com/trials/the-family-investigation-of-nephropathy-and-diabetes-study-4377https://curecurrent.com/trials/insulin-resistance-intervention-after-stroke-trial-4378https://curecurrent.com/trials/yo-puedo-diabetes-self-management-education-mhealth-in-mexico-city-4379https://curecurrent.com/trials/determinants-of-diabetes-remission-after-gastric-bypass-surgery-4380https://curecurrent.com/trials/a-phase-2a-study-to-assess-safety-pharmacokinetics-of-sustained-release-sodium-nitrite-in-patients-with-diabetic-pain-4381https://curecurrent.com/trials/the-diabetes-prevention-trial-of-type-1-diabetes-dpt-1-4382https://curecurrent.com/trials/a-study-comparing-the-dulaglutide-pen-and-the-semaglutide-pen-4383https://curecurrent.com/trials/an-emotion-focused-intervention-for-glycemic-control-in-t2d-4384https://curecurrent.com/trials/study-to-test-efficacy-of-real-time-reminders-on-apple-watch-to-decrease-late-or-missed-meal-boluses-4385https://curecurrent.com/trials/comparison-of-the-safety-and-efficacy-of-hoe901-u300-with-lantus-in-older-patients-with-type2-diabetes-insufficiently-co-4386https://curecurrent.com/trials/preventing-hypoglycemia-during-exercise-with-proactive-snacking-on-closed-loop-4387https://curecurrent.com/trials/increasing-use-of-continuous-glucose-monitors-in-publicly-insured-youth-with-type-1-diabetes-4388https://curecurrent.com/trials/investigation-of-safety-and-efficacy-of-once-daily-semaglutide-in-obese-subjects-without-diabetes-mellitus-4389https://curecurrent.com/trials/a-phase-2-trial-of-iw-1973-a-stimulator-of-soluble-guanylate-cyclase-sgc-in-patients-with-stable-type-2-diabetes-and-hyp-4390https://curecurrent.com/trials/uss-virginia-closed-loop-for-overnight-control-in-type-1-diabetes-4391https://curecurrent.com/trials/study-of-abatacept-orencia-to-treat-primary-biliary-cirrhosis-4392https://curecurrent.com/trials/bempedoic-acid-ezetimibe-fixed-dose-combination-fdc-study-in-patients-with-type-2-diabetes-and-elevated-ldl-c-4393https://curecurrent.com/trials/development-of-an-advisory-system-for-glycemic-control-during-the-menstrual-cycle-in-patient-with-type-1-diabetes-4394https://curecurrent.com/trials/effect-of-dapagliflozin-on-inflammation-and-endothelial-function-4395https://curecurrent.com/trials/a-study-investigating-the-pharmacokinetics-of-a-single-dose-administration-of-cotadutide-4396https://curecurrent.com/trials/larval-debridement-therapy-versus-sharp-debridement-to-remove-biofilm-4397https://curecurrent.com/trials/bortezomib-dexamethasone-bd-followed-by-autologous-stem-cell-transplantation-and-maintenance-bortezomib-dexamethasone-fo-4398https://curecurrent.com/trials/evaluating-the-effects-of-eecp-on-circulation-blood-glucose-level-and-blood-pressure-in-type-2-diabetes-mellitus-4399https://curecurrent.com/trials/single-use-negative-pressure-wound-therapy-system-vs-traditional-negative-pressure-wound-therapy-system-tnpwt-4400https://curecurrent.com/trials/active-surveillance-research-program-for-the-assessment-of-the-safety-and-the-effectiveness-of-linagliptin-4401https://curecurrent.com/trials/medtronic-670g-insulin-pump-and-the-impact-on-glycemic-control-quality-of-life-and-compliance-4402https://curecurrent.com/trials/impact-of-hypoglycemia-unawareness-on-brain-metabolism-cognition-in-t1dm-4403https://curecurrent.com/trials/comparison-of-different-insulin-dosing-algorithms-using-hepatic-directed-vesicle-insulin-lispro-and-insulin-degludec-4404https://curecurrent.com/trials/teencope-an-internet-coping-skills-training-program-for-teens-with-type-1-diabetes-4405https://curecurrent.com/trials/vitamin-d-for-established-type-2-diabetes-ddm2-4406https://curecurrent.com/trials/telemedicine-monitoring-of-nocturnal-incidents-4407https://curecurrent.com/trials/stress-management-among-latinos-with-type-2-diabetes-4408https://curecurrent.com/trials/chronicare-for-type-2-diabetes-chronicare-t2d-4409https://curecurrent.com/trials/post-prandial-effects-of-extra-virgin-olive-oil-on-endothelial-function-in-adults-at-risk-for-type-2-diabetes-4410https://curecurrent.com/trials/effect-and-safety-of-liraglutide-3-0-mg-in-subjects-with-overweight-or-obesity-and-type-2-diabetes-mellitus-treated-with-4411https://curecurrent.com/trials/a-multiple-ascending-dose-study-to-evaluate-safety-and-tolerability-of-bfkb8488a-in-participants-with-type-2-diabetes-me-4412https://curecurrent.com/trials/a-study-of-ly900014-compared-to-insulin-lispro-in-participants-with-type-2-diabetes-4413https://curecurrent.com/trials/pilot-sleep-intervention-to-improve-diabetes-management-in-school-aged-children-4414https://curecurrent.com/trials/international-consortium-investigating-early-vitrectomy-in-diabetic-macular-edema-patients-4415https://curecurrent.com/trials/effects-of-walnut-consumption-on-endothelial-function-in-type-2-diabetes-4416https://curecurrent.com/trials/walnut-ingestion-in-adults-at-risk-for-diabetes-effects-on-body-composition-diet-quality-and-cardiac-risk-measures-4417https://curecurrent.com/trials/pilot-sugar-reduction-intervention-in-kiritimati-teenagers-4418https://curecurrent.com/trials/addressing-uncontrolled-diabetes-in-primary-care-a-lifestyle-redesign-approach-4419https://curecurrent.com/trials/metabolic-study-of-sleep-apnea-in-men-and-women-4420https://curecurrent.com/trials/spatial-frequency-domain-imaging-sfd-for-assessment-of-diabetic-foot-ulcer-development-and-healing-4421https://curecurrent.com/trials/continuous-glucose-monitoring-in-critically-ill-4422https://curecurrent.com/trials/study-of-da-9801-to-treat-diabetic-neuropathy-4423https://curecurrent.com/trials/evaluating-clinical-acceptance-of-a-npwt-wound-care-system-4424https://curecurrent.com/trials/a-phase-ii-trial-to-examine-the-effect-of-subcutaneous-exenatide-bydureon-on-glucose-control-in-patients-with-type-i-dia-4425https://curecurrent.com/trials/a-study-comparing-cardiovascular-effects-of-ticagrelor-versus-placebo-in-patients-with-type-2-diabetes-mellitus-4426https://curecurrent.com/trials/evaluation-of-physician-based-decision-support-4427https://curecurrent.com/trials/increase-in-capillary-plexus-density-level-following-the-use-of-ozurdex-for-the-treatment-of-dme-4428https://curecurrent.com/trials/continuous-glucose-monitoring-cgm-with-a-low-carbohydrate-diet-to-reduce-weight-in-patients-with-pre-diabetes-4429https://curecurrent.com/trials/use-of-continuous-glucose-monitoring-system-with-intensive-feedback-in-adolescents-with-poorly-controlled-type-1-diabete-4430https://curecurrent.com/trials/learning-to-breathe-a-randomized-controlled-trial-to-lower-diabetes-risk-in-adolescent-girls-4431https://curecurrent.com/trials/treatment-of-mild-gestational-diabetes-with-glyburide-versus-placebo-4432https://curecurrent.com/trials/testing-the-influence-of-different-sugary-drink-warning-label-designs-4433https://curecurrent.com/trials/effect-of-nesiritide-infusion-on-insulin-sensitivity-in-healthy-obese-insulin-resistant-subjects-4434https://curecurrent.com/trials/povidone-iodine-vs-avenova-a-pre-injection-disinfection-study-pave-study-4435https://curecurrent.com/trials/comparison-study-of-insulin-glargine-and-nph-insulin-4436https://curecurrent.com/trials/an-observational-study-to-understand-challenges-associated-with-progression-of-insulin-therapy-in-type-2-diabetes-4437https://curecurrent.com/trials/comparative-user-experiences-with-bd-nano-pro-4mm-x-32g-extra-thin-wall-pen-needle-vs-three-commercially-available-pen-n-4438https://curecurrent.com/trials/investigating-markers-of-energy-metabolism-in-pregnant-women-with-insulin-resistance-4439https://curecurrent.com/trials/warming-up-to-sensors-does-site-warming-improve-continuous-glucose-monitor-performance-4440https://curecurrent.com/trials/continuous-glucose-monitoring-in-youth-with-type-2-diabetes-4441https://curecurrent.com/trials/intensive-management-for-gestational-diabetes-4442https://curecurrent.com/trials/insulin-degludec-titration-using-mobile-insulin-dosing-system-4443https://curecurrent.com/trials/evaluation-of-prevent-in-underserved-populations-4444https://curecurrent.com/trials/validation-of-a-creation-health-assessment-tool-for-patients-in-a-diabetic-outpatient-population-4445https://curecurrent.com/trials/veterans-inpatient-insulin-study-and-transition-to-outpatient-therapy-4446https://curecurrent.com/trials/metformin-therapy-for-overweight-adolescents-with-type-1-diabetes-4447https://curecurrent.com/trials/quality-iq-patient-simulation-physician-practice-measurement-and-engagement-4448https://curecurrent.com/trials/mini-dose-glucagon-to-treat-non-severe-hypoglycemia-4449https://curecurrent.com/trials/randomization-of-early-diabetes-screening-among-obese-pregnant-women-4450https://curecurrent.com/trials/fuel-utilization-diet-composition-and-exercise-in-african-american-women-4451https://curecurrent.com/trials/the-use-of-mini-dose-glucagon-to-prevent-exercise-induced-hypoglycemia-in-type-1-diabetes-4452https://curecurrent.com/trials/atg-gcsf-in-new-onset-type-1-diabetes-4453https://curecurrent.com/trials/assistive-exoskeletons-to-enable-wearable-rehabilitation-robotics-4454https://curecurrent.com/trials/efficacy-and-safety-of-oral-semaglutide-versus-placebo-in-subjects-with-type-2-diabetes-mellitus-treated-with-insulin-4455https://curecurrent.com/trials/patient-and-provider-assessment-of-lipid-management-registry-4456https://curecurrent.com/trials/paleolithic-diets-vs-t2d-and-improvements-in-the-metabolic-syndrome-4457https://curecurrent.com/trials/ohi-randomized-control-trial-to-evaluate-efficacy-acceptability-and-perception-of-benefit-of-an-innovative-custom-afo-4458https://curecurrent.com/trials/placebo-controlled-clinical-nutrition-study-of-the-safety-and-metabolic-effects-of-two-medical-foods-in-type-2-diabetes-4459https://curecurrent.com/trials/pk-pd-study-of-u-500-regular-insulin-4460https://curecurrent.com/trials/diabetes-adolescent-and-family-group-therapy-4461https://curecurrent.com/trials/empaglifozin-in-early-diabetic-kidney-disease-4462https://curecurrent.com/trials/oral-glucose-tolerance-testing-after-gestational-diabetes-4463https://curecurrent.com/trials/fatty-acid-radiotracer-comparison-study-in-heart-failure-patients-4464https://curecurrent.com/trials/ipilimumab-vaccine-therapy-in-treating-patients-with-locally-advanced-unresectable-or-metastatic-pancreatic-cancer-4465https://curecurrent.com/trials/diabetes-strengths-study-pilot-of-provider-delivered-strengths-based-intervention-4466https://curecurrent.com/trials/type-1-diabetes-telemedicine-4467https://curecurrent.com/trials/in-home-assessment-of-a-smart-foot-mat-for-prevention-of-diabetic-foot-ulcers-4468https://curecurrent.com/trials/shared-decision-making-in-diabetes-prevention-for-women-with-a-history-of-gdm-4469https://curecurrent.com/trials/baby-bump-lifestyle-intervention-supplement-study-4470https://curecurrent.com/trials/effect-of-fresh-amniotic-membrane-in-the-treatment-of-diabetic-foot-ulcers-4471https://curecurrent.com/trials/affinity-prospective-diabetic-foot-trial-crossover-group-4472https://curecurrent.com/trials/physical-activity-behavior-change-for-older-adults-after-dysvascular-amputation-4473https://curecurrent.com/trials/efficacy-and-safety-of-oral-semaglutide-versus-placebo-in-subjects-with-type-2-diabetes-and-moderate-renal-impairment-4474https://curecurrent.com/trials/effect-of-maternal-diabetes-on-brain-development-as-measured-by-neonatal-electroencephalogram-eeg-4475https://curecurrent.com/trials/a-mobile-personal-health-record-for-behavioral-health-homes-4476https://curecurrent.com/trials/de-novo-lipogenesis-lipid-and-carbohydrate-metabolism-in-non-alcoholic-fatty-liver-disease-4477https://curecurrent.com/trials/g-pen-compared-to-lilly-glucagon-for-hypoglycemia-rescue-in-adults-with-type-1-diabetes-4478https://curecurrent.com/trials/smartphone-utilization-for-glucose-monitoring-and-antenatal-reporting-4479https://curecurrent.com/trials/effects-of-leptin-replacement-in-children-4480https://curecurrent.com/trials/effects-of-human-leptin-replacement-4481https://curecurrent.com/trials/vorapaxar-as-an-add-on-antiplatelet-therapy-in-patients-with-and-without-diabetes-mellitus-4482https://curecurrent.com/trials/efficacy-and-safety-of-sotagliflozin-in-young-adult-patients-with-type-1-diabetes-mellitus-and-elevated-hemoglobin-a1c-4483https://curecurrent.com/trials/gene-expression-variation-and-implant-wound-healing-among-smokers-and-diabetics-4484https://curecurrent.com/trials/safety-and-efficacy-of-sotagliflozin-lx4211-in-patients-with-inadequately-controlled-type-1-diabetes-mellitus-4485https://curecurrent.com/trials/efficacy-safety-and-tolerability-study-of-sotagliflozin-as-adjunct-therapy-in-adult-patients-with-type-1-diabetes-mellit-4486https://curecurrent.com/trials/dose-ranging-study-in-patients-with-type-1-diabetes-mellitus-4487https://curecurrent.com/trials/a-phase-3-study-to-evaluate-the-safety-of-sotagliflozin-in-patients-with-type-1-diabetes-who-have-inadequate-glycemic-co-4488https://curecurrent.com/trials/indigo-2-the-effect-of-high-water-intake-on-glucose-regulation-in-low-drinkers-4489https://curecurrent.com/trials/a-clinical-study-to-evaluate-safety-efficacy-of-the-combination-of-aliskiren-valsartan-hydrochlorothiazide-in-diabetic-h-4490https://curecurrent.com/trials/metformin-and-muscle-in-insulin-resistant-older-veterans-4491https://curecurrent.com/trials/imatinib-treatment-in-recent-onset-type-1-diabetes-mellitus-4492https://curecurrent.com/trials/determining-metabolic-effects-of-valproate-and-antipsychotic-therapy-4493https://curecurrent.com/trials/vitamin-d-insulin-resistance-and-cardiovascular-disease-4494https://curecurrent.com/trials/cold-induced-changes-in-white-adipose-4495https://curecurrent.com/trials/developing-enhanced-prediction-models-4496https://curecurrent.com/trials/gan-lee-evaluation-of-new-biosimilar-for-type-1-lispro-4497https://curecurrent.com/trials/verapamil-for-beta-cell-survival-therapy-in-type-1-diabetes-4498https://curecurrent.com/trials/diabetes-prevention-program-for-obese-latino-youth-4499https://curecurrent.com/trials/the-insulin-only-bionic-pancreas-bridging-study-pediatric-transitional-study-4500https://curecurrent.com/trials/association-between-vitamin-d-and-inflammation-and-diabetes-risk-in-morbidly-obese-pre-menopausal-women-4501https://curecurrent.com/trials/naltrexone-and-hypoglycemia-in-type-1-diabetes-4502https://curecurrent.com/trials/effect-of-high-fat-and-high-glycemic-diets-4503https://curecurrent.com/trials/healthy-living-partnership-to-prevent-diabetes-4504https://curecurrent.com/trials/a-randomized-double-blinded-study-to-examine-the-use-of-n-acetyl-cysteine-for-the-prevention-and-treatment-of-haaf-in-pa-4505https://curecurrent.com/trials/almased-multi-center-diabetes-intervention-trial-4506https://curecurrent.com/trials/medically-reproducing-bariatric-surgery-4507https://curecurrent.com/trials/a-study-to-evaluate-time-in-range-in-type-2-diabetics-using-afrezza-plus-basal-insulin-compared-to-multiple-daily-inject-4508https://curecurrent.com/trials/effect-of-liraglutide-on-automated-closed-loop-glucose-control-in-type-1-diabetes-4509https://curecurrent.com/trials/adaptation-of-the-diabetes-prevention-program-for-primary-care-4510https://curecurrent.com/trials/bone-and-vascular-health-in-postmenopausal-women-with-type-1-diabetes-4511https://curecurrent.com/trials/evaluating-for-type-2-diabetes-in-the-very-early-postpartum-period-4512https://curecurrent.com/trials/resilience-promotion-in-teens-with-type-1-diabetes-preventing-negative-outcomes-4513https://curecurrent.com/trials/insulin-dosage-software-program-for-people-with-type-1-and-type-2-diabetes-4514https://curecurrent.com/trials/effects-of-simulated-passive-jogging-device-on-glucose-homeostasis-muscle-strength-and-endurance-4515https://curecurrent.com/trials/visceral-adiposity-and-diabetes-translating-form-to-function-using-imaging-4516https://curecurrent.com/trials/diabetes-ckd-lifestyle-technology-study-4517https://curecurrent.com/trials/a-study-to-evaluate-the-safety-of-thr-687-in-subjects-with-diabetic-macular-edema-dme-4518https://curecurrent.com/trials/dose-finding-of-pb-119-administered-subcutaneously-once-weekly-versus-placebo-in-subjects-with-type-2-diabetes-4519https://curecurrent.com/trials/salsalate-therapy-to-reduce-insulin-resistance-and-cardiovascular-risk-4520https://curecurrent.com/trials/efficacy-and-safety-of-semaglutide-versus-canagliflozin-as-add-on-to-metformin-in-subjects-with-type-2-diabetes-4521https://curecurrent.com/trials/diabetes-effects-on-long-term-implant-survival-and-success-4522https://curecurrent.com/trials/cardiovascular-disease-risk-factors-in-chinese-american-immigrants-4523https://curecurrent.com/trials/evaluation-of-glucose-control-in-patients-with-diabetes-4524https://curecurrent.com/trials/use-of-cog-by-patients-with-diabetes-mellitus-4525https://curecurrent.com/trials/sleep-promotion-to-improve-diabetes-management-in-adolescents-with-t1d-4526https://curecurrent.com/trials/user-evaluation-of-the-invasive-component-of-the-cnoga-tensortip-combo-glucometer-cog-4527https://curecurrent.com/trials/effect-of-a-plant-rich-diet-on-in-people-with-type-2-diabetes-and-obesity-4528https://curecurrent.com/trials/ertugliflozin-versus-hydrochlorothiazide-in-reducing-sympathetic-neural-overactivity-in-patients-with-hypertension-and-r-4529https://curecurrent.com/trials/evaluating-outcomes-for-ethnically-diverse-patients-with-type-2-diabetes-participating-in-a-diabetes-education-program-4530https://curecurrent.com/trials/a-trial-of-18f-av-133-positron-emission-tomography-pet-4531https://curecurrent.com/trials/the-effects-of-a-low-carbohydrate-non-ketogenic-diet-versus-standard-diabetes-diet-on-glycemic-control-in-type-1-diabete-4532https://curecurrent.com/trials/examination-of-the-anti-inflammatory-and-insulin-sensitizing-properties-of-doxycycline-in-humans-4533https://curecurrent.com/trials/this-study-tests-a-new-medicine-called-bi-685509-in-patients-that-have-kidney-problems-because-of-diabetes-the-study-tes-4534https://curecurrent.com/trials/feasibility-trial-of-the-bios-device-for-continuous-glucose-monitoring-4535https://curecurrent.com/trials/primary-care-based-physical-activity-for-diabetic-latinas-4536https://curecurrent.com/trials/first-research-study-of-the-possible-new-medicine-nnc0113-2023-in-healthy-men-4537https://curecurrent.com/trials/intensive-uric-acid-lowering-with-verinurad-and-febuxostat-in-patients-with-albuminuria-4538https://curecurrent.com/trials/adjusting-insulin-delivery-to-activity-4539https://curecurrent.com/trials/facilitated-release-of-endogenous-enterokines-4540https://curecurrent.com/trials/carolina-cardiovascular-outcome-study-of-linagliptin-versus-glimepiride-in-patients-with-type-2-diabetes-4541https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-jnj-64565111-in-severely-obese-participants-with-type-2-diabetes-mellitus-4542https://curecurrent.com/trials/impact-of-early-implementation-of-narrative-medicine-techniques-on-patient-centered-attitudes-of-medical-students-4543https://curecurrent.com/trials/glucose-measurement-using-microneedle-patches-4544https://curecurrent.com/trials/a-sleep-intervention-sleep-extend-for-young-adults-at-risk-for-type-2-diabetes-4545https://curecurrent.com/trials/accelerometer-use-in-the-prevention-of-exercise-associated-hypoglycemia-in-type-1-diabetes-outpatient-exercise-protocol-4546https://curecurrent.com/trials/evaluation-of-the-dreamed-advisor-pro-for-automated-insulin-pump-setting-adjustments-in-children-and-adolescents-with-ty-4547https://curecurrent.com/trials/multicenter-trial-to-evaluate-the-effect-of-dapagliflozin-on-the-incidence-of-cardiovascular-events-4548https://curecurrent.com/trials/study-diet-and-exercise-study-to-improve-brain-blood-flow-blood-flow-improvement-trial-4549https://curecurrent.com/trials/stroke-hyperglycemia-insulin-network-effort-shine-trial-4550https://curecurrent.com/trials/sitagliptin-for-hyperglycemia-in-patients-with-t2dm-undergoing-cardiac-surgery-4551https://curecurrent.com/trials/sleep-effectiveness-and-insulin-and-glucose-homeostasis-4552https://curecurrent.com/trials/paradoxical-stimulation-of-hepatic-glucose-production-with-dapagliflozin-4553https://curecurrent.com/trials/the-impact-of-fitness-and-mineralocorticoid-receptor-blockade-on-vascular-dysfunction-in-adults-with-type-1-diabetes-4554https://curecurrent.com/trials/the-mechanism-of-action-of-the-unite-biomatrix-in-diabetic-foot-ulcer-4555https://curecurrent.com/trials/effect-of-combined-incretin-based-therapy-plus-canagliflozin-on-glycemic-control-and-the-compensatory-rise-in-hepatic-gl-4556https://curecurrent.com/trials/measurement-of-glucose-glycogen-metabolism-in-humans-using-magnetic-resonance-at-4-or-7-tesla-4557https://curecurrent.com/trials/brain-imaging-study-of-adults-with-autism-spectrum-disorders-4558https://curecurrent.com/trials/screening-for-patients-needing-kidney-kidney-pancreas-or-islet-cell-transplant-4559https://curecurrent.com/trials/effects-of-caloric-restriction-alone-versus-postoperative-caloric-restriction-following-bariatric-surgery-on-glucose-met-4560https://curecurrent.com/trials/kidney-disease-biomarkers-4561https://curecurrent.com/trials/liraglutide-in-overweight-patients-with-type-1-diabetes-4562https://curecurrent.com/trials/partners-for-better-health-in-adolescent-type-2-diabetes-the-buddy-study-4563https://curecurrent.com/trials/effects-of-worksite-wellness-interventions-on-vascular-function-insulin-sensitivity-and-high-density-lipoprotein-in-over-4564https://curecurrent.com/trials/family-management-of-childhood-diabetes-study-4565https://curecurrent.com/trials/the-bihormonal-ilet-bionic-pancreas-feasibility-study-4566https://curecurrent.com/trials/mood-and-insulin-resistance-in-adolescents-at-risk-for-diabetes-4567https://curecurrent.com/trials/a-trial-of-s-s-reboxetine-in-patients-with-chronic-painful-diabetic-peripheral-neuropathy-4568https://curecurrent.com/trials/a-suspected-association-between-sarcoidosis-and-development-of-diabetes-mellitus-4569https://curecurrent.com/trials/comparison-of-outreach-methods-to-encourage-enrollment-in-diabetes-prevention-and-weight-management-programs-4570https://curecurrent.com/trials/selecting-insulin-analogs-for-closed-loop-control-using-multiplex-pharmacokinetic-profiling-4571https://curecurrent.com/trials/pediatric-type-1-diabetes-and-retinopathy-4572https://curecurrent.com/trials/deferoxamine-for-the-treatment-of-hemochromatosis-4573https://curecurrent.com/trials/one-drop-experts-program-for-type-2-diabetes-self-management-impact-on-a1c-4574https://curecurrent.com/trials/efficacy-of-glucagon-in-the-prevention-of-hypoglycemia-during-mild-exercise-4575https://curecurrent.com/trials/the-use-of-a-water-soluble-under-the-tongue-sublingual-cbd-tablet-for-treating-pain-associated-with-diabetic-peripheral-4576https://curecurrent.com/trials/better-me-within-trial-to-improve-lifestyle-behaviors-in-african-americans-4577https://curecurrent.com/trials/telemedicine-for-adolescents-with-insulin-dependent-diabetes-4578https://curecurrent.com/trials/study-to-develop-a-tool-to-estimate-the-kidney-function-in-databases-without-laboratory-data-4579https://curecurrent.com/trials/tissue-studies-of-human-eye-diseases-4580https://curecurrent.com/trials/effect-of-aerobic-interval-training-on-cardiovascular-function-in-type-2-diabetes-4581https://curecurrent.com/trials/incentivized-smoking-cessation-for-diabetics-4582https://curecurrent.com/trials/evaluation-of-the-effects-of-canagliflozin-on-renal-and-cardiovascular-outcomes-in-participants-with-diabetic-nephropath-4583https://curecurrent.com/trials/thyroid-hormone-to-induce-non-insulin-mediated-glucose-disposal-in-people-with-insulin-receptor-mutations-4584https://curecurrent.com/trials/cultivating-healthy-environments-in-families-with-type-1-diabetes-chef-4585https://curecurrent.com/trials/phase-4-investigational-study-to-evaluate-metformin-xr-monotherapy-versus-metformin-ir-monotherapy-in-subjects-with-type-4586https://curecurrent.com/trials/assessment-of-the-effects-of-a-dpp-4-inhibitor-sitagliptin-januvia-on-immune-function-in-healthy-individuals-4587https://curecurrent.com/trials/targeted-cpap-therapy-for-obstructive-sleep-apnea-in-pregnancy-4588https://curecurrent.com/trials/fams-mobile-health-intervention-for-diabetes-self-care-support-4589https://curecurrent.com/trials/a-104-week-clinical-trial-comparing-long-term-glycaemic-control-of-insulin-degludec-liraglutide-ideglira-versus-insulin-4590https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-multiple-ascending-doses-of-kq-791-in-diabetes-mellitus-4591https://curecurrent.com/trials/a-specialized-diet-for-the-unique-metabolic-characteristics-of-peripubertal-african-american-girls-4592https://curecurrent.com/trials/fit-for-two-incorporating-wearable-trackers-into-clinical-care-for-pregnant-women-with-diabetes-fft-4593https://curecurrent.com/trials/lucica-glycated-albumin-l-clinical-program-pivotal-study-4594https://curecurrent.com/trials/community-based-adolescent-diabetes-prevention-program-4595https://curecurrent.com/trials/efficacy-and-safety-of-continuous-subcutaneous-insulin-infusion-of-faster-acting-insulin-aspart-compared-to-novorapid-in-4596https://curecurrent.com/trials/effects-of-capros-in-patients-with-type-1-diabetes-4597https://curecurrent.com/trials/role-of-cardiometabolic-risk-factors-in-childhood-bone-development-4598https://curecurrent.com/trials/vitamin-k-to-slow-progression-of-dyslipidemia-and-diabetes-risk-vita-k-n-kids-study-ii-4599https://curecurrent.com/trials/vitamin-k-and-glucose-metabolism-in-adults-at-risk-for-diabetes-vita-k-n-adults-study-4600https://curecurrent.com/trials/vitamin-k-and-glucose-metabolism-in-children-at-risk-for-diabetes-vita-k-n-kids-study-4601https://curecurrent.com/trials/topically-applied-bisphosphocin-nu-3-on-infected-diabetic-ulcers-of-subjects-with-type-i-or-ii-diabetes-mellitus-4602https://curecurrent.com/trials/a-phase-2-study-of-cyclo-z-in-subjects-with-type-2-diabetes-4603https://curecurrent.com/trials/developing-a-lifestyle-intervention-for-south-asians-4604https://curecurrent.com/trials/the-ilet-introduction-study-a-feasibility-study-of-the-ilet-a-fully-integrated-bihormonal-bionic-pancreas-4605https://curecurrent.com/trials/acthar-for-treatment-of-proteinuria-in-diabetic-nephropathy-patients-4606https://curecurrent.com/trials/study-of-the-effect-of-intradialytic-vasopressin-on-chronic-hypertension-in-patients-with-end-stage-renal-disease-4607https://curecurrent.com/trials/mastering-diabetes-pilot-study-4608https://curecurrent.com/trials/single-ascending-dose-study-of-mk-1092-in-healthy-participants-and-in-participants-with-type-1-and-type-2-diabetes-melli-4609https://curecurrent.com/trials/motor-assisted-cycling-and-fes-cycling-for-postprandial-glucose-in-diabetic-patients-with-adl-disability-4610https://curecurrent.com/trials/lidocaine-for-diabetic-peripheral-neuropathy-4611https://curecurrent.com/trials/anti-inflammatory-therapy-with-anakinra-in-newly-diagnosed-type-1-diabetes-4612https://curecurrent.com/trials/medtronic-minimed-overnight-closed-loop-system-4613https://curecurrent.com/trials/diabetic-ketoacidosis-and-its-impact-on-the-brain-4614https://curecurrent.com/trials/short-term-effects-of-leptin-in-people-with-lipodystrophy-4615https://curecurrent.com/trials/evaluation-of-a-non-invasive-brain-compliance-measurement-device-4616https://curecurrent.com/trials/a-38-week-trial-comparing-effect-and-safety-of-insulin-degludec-insulin-aspart-vs-insulin-glargine-plus-insulin-aspart-i-4617https://curecurrent.com/trials/phase-ii-safety-and-efficacy-study-of-oral-ormd-0801-in-patients-with-type-2-diabetes-mellitus-4618https://curecurrent.com/trials/reactive-oxygen-species-in-the-pathogenesis-of-diabetic-complications-4619https://curecurrent.com/trials/remote-monitoring-of-diabetes-in-young-children-with-type-1-diabetes-4620https://curecurrent.com/trials/transition-to-adult-care-in-type-1-diabetes-4621https://curecurrent.com/trials/healthy-foods-and-education-to-treat-diabetes-4622https://curecurrent.com/trials/examination-of-the-pancreas-in-new-onset-diabetes-4623https://curecurrent.com/trials/evaluation-of-corneal-confocal-microscopy-for-the-identification-and-prediction-of-neuropathy-in-type-1-diabetes-4624https://curecurrent.com/trials/n2-1-carboxyethyl-2-deoxyguanosine-cedg-a-potential-biomarker-for-diabetes-4625https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-selonsertib-gs-4997-in-participants-with-diabetic-kidney-disease-4626https://curecurrent.com/trials/regulation-of-maternal-fuel-supply-and-neonatal-adiposity-4627https://curecurrent.com/trials/mobile-health-app-to-reduce-diabetes-in-latina-women-4628https://curecurrent.com/trials/high-dose-cholecalciferol-to-reduce-the-incidence-of-gestational-diabetes-in-high-risk-pregnant-women-4629https://curecurrent.com/trials/effectiveness-of-adding-subcutaneous-long-acting-glargine-to-insulin-drip-therapy-compared-with-standard-insulin-drip-th-4630https://curecurrent.com/trials/glycemic-response-of-bean-and-rice-meals-in-type-2-diabetes-mellitus-4631https://curecurrent.com/trials/using-peer-mentors-to-support-pact-team-efforts-to-improve-diabetes-control-4632https://curecurrent.com/trials/online-wic-nutrition-education-to-promote-farmers-market-fruit-and-vegetable-purchases-and-consumption-4633https://curecurrent.com/trials/dapagliflozin-patient-satisfaction-survey-4634https://curecurrent.com/trials/evaluation-of-an-ascensia-diabetes-care-onyx-plus-investigational-blood-glucose-monitoring-system-4635https://curecurrent.com/trials/an-investigation-into-the-anti-hypertensive-and-potential-anti-inflammatory-actions-of-dapagliflozin-4636https://curecurrent.com/trials/evaluating-the-acute-glycemic-response-to-different-strategies-of-breaking-up-sedentary-time-4637https://curecurrent.com/trials/community-servings-food-as-medicine-for-diabetes-4638https://curecurrent.com/trials/treatment-of-diabetes-in-patients-with-systolic-heart-failure-4639https://curecurrent.com/trials/a-trial-in-painful-diabetic-peripheral-neuropathy-with-grt3983y-4640https://curecurrent.com/trials/foot-self-care-in-older-adults-4641https://curecurrent.com/trials/supporting-american-indian-alaska-native-mothers-and-daughters-in-reducing-gestational-diabetes-risk-4642https://curecurrent.com/trials/improving-health-in-diabetes-project-4643https://curecurrent.com/trials/a-dose-response-of-the-effects-of-exendin-9-39-on-gi-symptoms-and-food-intake-4644https://curecurrent.com/trials/rise-to-prevent-cardiovascular-disease-in-african-americans-4645https://curecurrent.com/trials/the-effect-of-simple-basal-insulin-titration-metformin-plus-liraglutide-for-type-2-diabetes-with-very-elevated-hba1c-the-4646https://curecurrent.com/trials/miroderm-h2h-dfu-study-4647https://curecurrent.com/trials/beta-cell-restoration-through-fat-mitigation-4648https://curecurrent.com/trials/a-study-in-type-2-diabetic-patients-with-repeated-doses-of-e1-in-combination-with-g1-4649https://curecurrent.com/trials/a-study-in-type-1-diabetic-patients-with-repeated-doses-of-e1-in-combination-with-g1-4650https://curecurrent.com/trials/expressgraft-c9t1-skin-tissue-as-a-treatment-of-diabetic-foot-ulcers-4651https://curecurrent.com/trials/clinical-usability-of-intranasal-glucagon-in-treatment-of-hypoglycemia-4652https://curecurrent.com/trials/efficacy-and-safety-of-semaglutide-versus-dulaglutide-as-add-on-to-metformin-in-subjects-with-type-2-diabetes-4653https://curecurrent.com/trials/assessing-insulin-sensitivity-and-diabetes-risk-in-childhood-cancer-survivors-treated-with-abdominal-irradiation-4654https://curecurrent.com/trials/study-to-evaluate-cort125134-in-participants-with-cushing-s-syndrome-4655https://curecurrent.com/trials/epigenetics-of-muscle-insulin-resistance-4656https://curecurrent.com/trials/orion-effects-of-cenicriviroc-on-insulin-sensitivity-in-subjects-with-prediabetes-or-type-2-diabetes-mellitus-t2dm-and-s-4657https://curecurrent.com/trials/stand-move-at-work-4658https://curecurrent.com/trials/duration-of-the-honeymoon-phase-of-type-1-diabetes-a-comparison-of-insulins-detemir-glargine-and-nph-4659https://curecurrent.com/trials/hyaluronidase-effect-on-infusion-set-life-4660https://curecurrent.com/trials/the-management-of-diabetes-in-everyday-life-program-4661https://curecurrent.com/trials/the-effect-of-dopamine-on-diabetic-retinopathy-4662https://curecurrent.com/trials/the-health-access-and-recovery-peer-program-4663https://curecurrent.com/trials/early-detection-and-prevention-of-mild-cognitive-impairment-due-to-cerebrovascular-disease-4664https://curecurrent.com/trials/electronic-decision-support-for-intervention-in-poorly-controlled-type-2-diabetes-4665https://curecurrent.com/trials/a-comparison-of-two-treatment-strategies-in-older-participants-with-type-2-diabetes-mellitus-t2dm-4666https://curecurrent.com/trials/a-study-of-ly2409021-in-participants-with-type-2-diabetes-mellitus-4667https://curecurrent.com/trials/short-term-sugary-beverage-consumption-on-glucose-control-and-cardiovascular-disease-risk-factors-4668https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-ly3053102-in-participants-with-type-2-diabetes-4669https://curecurrent.com/trials/a-study-of-ly900014-and-insulin-lispro-with-an-external-continuous-subcutaneous-insulin-infusion-system-in-adult-partici-4670https://curecurrent.com/trials/researching-cardiovascular-events-with-a-weekly-incretin-in-diabetes-rewind-4671https://curecurrent.com/trials/equivalence-of-a-stable-liquid-glucagon-formulation-with-freshly-reconstituted-lyophilized-glucagon-4672https://curecurrent.com/trials/evaluation-of-vitrectomy-for-diabetic-macular-edema-4673https://curecurrent.com/trials/resilient-empowered-active-living-real-diabetes-study-4674https://curecurrent.com/trials/laser-ranibizumab-triamcinolone-for-diabetic-macular-edema-4675https://curecurrent.com/trials/evaluation-of-discomfort-associated-with-scleral-depression-during-retina-examinations-4676https://curecurrent.com/trials/hypogonadism-in-young-men-with-type-2-diabetes-4677https://curecurrent.com/trials/a-comparison-of-insulin-drip-protocols-in-labor-a-randomized-trial-4678https://curecurrent.com/trials/pet-ownership-and-glucose-control-in-early-adolescents-with-type-1-diabetes-4679https://curecurrent.com/trials/bloom-dm-behavioral-modification-and-lorcaserin-for-overweight-and-obesity-management-in-diabetes-mellitus-4680https://curecurrent.com/trials/glucose-and-lipid-metabolism-on-antipsychotic-medication-4681https://curecurrent.com/trials/exercise-facilitated-neurorehabilitation-in-diabetic-neuropathy-4682https://curecurrent.com/trials/inpatient-diabetes-on-corticosteroids-4683https://curecurrent.com/trials/liraglutide-actions-on-the-liver-effects-on-glucose-phosphorylation-4684https://curecurrent.com/trials/absolute-bioavailability-study-with-bexagliflozin-4685https://curecurrent.com/trials/a-study-to-test-safety-and-efficacy-of-baricitinib-in-participants-with-diabetic-kidney-disease-4686https://curecurrent.com/trials/impact-of-no-carrageenan-diet-on-glucose-tolerance-in-prediabetes-4687https://curecurrent.com/trials/a-pharmacist-coordinated-implementation-of-the-diabetes-prevention-program-4688https://curecurrent.com/trials/examining-genetic-influence-on-response-to-beta-blocker-medications-in-people-with-type-2-diabetes-4689https://curecurrent.com/trials/a-study-of-dulaglutide-ly2189265-in-participants-with-type-ii-diabetes-4690https://curecurrent.com/trials/blood-glucose-differences-between-left-arm-and-right-arm-using-a-continuous-glucose-monitor-4691https://curecurrent.com/trials/supporting-parents-of-young-children-with-type-1-diabetes-in-closed-loop-system-4692https://curecurrent.com/trials/high-risk-youth-with-poorly-controlled-diabetes-4693https://curecurrent.com/trials/rct-of-caloric-restriction-vs-alternate-day-fasting-in-non-alcoholic-fatty-liver-disease-4694https://curecurrent.com/trials/a-study-of-investigational-dulaglutide-doses-in-participants-with-type-2-diabetes-on-metformin-monotherapy-4695https://curecurrent.com/trials/clinical-usability-of-nasal-glucagon-in-treatment-of-hypoglycemia-in-children-and-adolescents-4696https://curecurrent.com/trials/efficacy-and-safety-of-nasal-glucagon-for-treatment-of-hypoglycemia-in-adults-4697https://curecurrent.com/trials/investigation-of-an-amino-acid-supplement-on-glucose-levels-in-obese-subjects-4698https://curecurrent.com/trials/a-study-comparing-dulaglutide-with-insulin-glargine-on-glycemic-control-in-participants-with-type-2-diabetes-t2d-and-mod-4699https://curecurrent.com/trials/changes-in-insulin-sensitivity-after-weight-loss-4700https://curecurrent.com/trials/clinical-startup-of-the-670g-closed-loop-insulin-delivery-system-4701https://curecurrent.com/trials/study-of-ly3016859-in-participants-with-diabetic-nephropathy-4702https://curecurrent.com/trials/tailored-diabetes-self-management-resources-4703https://curecurrent.com/trials/low-carb-vs-normal-carb-in-pregnancy-4704https://curecurrent.com/trials/a-study-of-ly2189102-in-patients-with-type-2-diabetes-4705https://curecurrent.com/trials/a-study-to-compare-the-effect-of-a-double-dose-of-two-long-acting-insulin-therapies-in-participants-with-type-2-diabetes-4706https://curecurrent.com/trials/trial-of-vasopressin-and-epinephrine-to-epinephrine-only-for-in-hospital-pediatric-cardiopulmonary-resuscitation-4707https://curecurrent.com/trials/a-study-in-participants-with-diabetic-kidney-disease-4708https://curecurrent.com/trials/enhancing-outcomes-through-goal-assessment-and-generating-engagement-in-diabetes-mellitus-4709https://curecurrent.com/trials/protocol-to-validate-the-performance-of-the-mellitus-glycated-cd59-elisa-for-gestational-diabetes-screening-4710https://curecurrent.com/trials/csii-pilot-in-adolescents-with-type-2-diabetes-4711https://curecurrent.com/trials/study-to-evaluate-the-effect-of-nicotinamide-riboside-on-immunity-4712https://curecurrent.com/trials/va-merit-a-comparative-efficacy-study-treatment-of-non-healing-diabetic-4713https://curecurrent.com/trials/safety-and-efficacy-of-inhaled-insulin-in-patients-with-diabetes-and-asthma-or-copd-4714https://curecurrent.com/trials/study-of-human-insulin-inhalation-powder-in-patients-with-type-2-diabetes-4715https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-insulin-in-patients-with-type-2-diabetes-4716https://curecurrent.com/trials/a-concordance-study-comparing-insulin-treatments-in-patients-with-type-2-diabetes-4717https://curecurrent.com/trials/qr-bromocriptine-as-an-adjunct-to-insulin-and-metformin-in-the-treatment-of-type-2-diabetes-4718https://curecurrent.com/trials/metabolic-causes-of-thrombosis-in-type-2-diabetes-mellitus-4719https://curecurrent.com/trials/metabolic-causes-of-thrombosis-in-type-2-diabetes-question-4-4720https://curecurrent.com/trials/mechanisms-of-hypoglycemia-associated-autonomic-dysfunction-q4-atomoxetine-4721https://curecurrent.com/trials/mechanisms-of-hypoglycemia-associated-autonomic-dysfunction-question-2-4722https://curecurrent.com/trials/hypoglycemia-associated-autonomic-failure-in-type-1-diabetes-mellitus-4723https://curecurrent.com/trials/single-hormone-closed-loop-study-with-pdt-sensor-4724https://curecurrent.com/trials/mechanisms-of-ramipril-reduction-in-the-onset-of-type-2-diabetes-4725https://curecurrent.com/trials/wireless-innovation-for-seniors-with-diabetes-mellitus-4726https://curecurrent.com/trials/adipose-derived-regenerative-cellular-therapy-of-chronic-wounds-4727https://curecurrent.com/trials/the-set-point-study-for-type-2-diabetes-evaluating-the-use-of-an-insulin-only-bionic-pancreas-system-in-type-2-diabetes-4728https://curecurrent.com/trials/a-real-world-trial-to-determine-efficacy-and-health-outcomes-of-toujeo-achieve-control-real-life-study-program-4729https://curecurrent.com/trials/photobiomodulation-for-the-treatment-of-diabetic-macular-edema-4730https://curecurrent.com/trials/type-2-diabetes-and-the-brain-in-adolescents-4731https://curecurrent.com/trials/a-clinical-trial-of-ginseng-in-diabetes-4732https://curecurrent.com/trials/dermacell-awm-in-chronic-wagner-grade-3-4-diabetic-foot-ulcers-4733https://curecurrent.com/trials/evaluating-the-impact-of-a-technologically-enhanced-personal-coaching-program-on-hemoglobin-a1c-in-type-2-diabetics-4734https://curecurrent.com/trials/the-insulin-only-bionic-pancreas-bridging-study-4735https://curecurrent.com/trials/characterization-of-diabetes-mellitus-in-fibrous-dysplasia-mccune-albright-syndrome-4736https://curecurrent.com/trials/prediction-using-connected-technologies-for-diabetes-4737https://curecurrent.com/trials/type-1-teamwork-a-tool-for-parents-of-adolescents-with-type-1-diabetes-4738https://curecurrent.com/trials/a-self-management-program-for-adults-with-both-schizophrenia-and-a-co-occurring-medical-condition-4739https://curecurrent.com/trials/the-effect-of-cognitive-behavioral-therapy-for-insomnia-on-type-2-diabetes-health-outcomes-4740https://curecurrent.com/trials/a-dose-finding-study-to-assess-the-effect-of-lik066-compared-to-placebo-or-empagliflozin-in-patients-with-type-2-diabete-4741https://curecurrent.com/trials/investigations-of-the-optimum-serum-bicarbonate-level-in-renal-disease-4742https://curecurrent.com/trials/controlled-clinical-study-to-determine-novel-health-benefits-of-cheese-consumption-4743https://curecurrent.com/trials/improving-beta-cell-function-in-mexican-american-women-with-prediabetes-4744https://curecurrent.com/trials/effects-of-metreleptin-in-type-1-diabetes-mellitus-4745https://curecurrent.com/trials/latinos-combating-diabetes-4746https://curecurrent.com/trials/exercise-physiology-study-4747https://curecurrent.com/trials/united-for-health-type-2-diabetes-prevention-in-latino-teens-4748https://curecurrent.com/trials/a-study-to-evaluate-medi0562-in-combination-with-immune-therapeutic-agents-in-adult-subjects-with-advanced-solid-tumors-4749https://curecurrent.com/trials/digestive-properties-of-carbohydrate-based-foods-4750https://curecurrent.com/trials/effectiveness-of-a-digital-therapeutic-on-type-2-diabetes-4751https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-dapagliflozin-with-and-without-saxagliptin-on-albuminuria-and-to-investigate-the-effec-4752https://curecurrent.com/trials/determination-of-the-pathophysicologic-collagen-changes-in-the-diabetic-achilles-tendon-4753https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-in-participants-with-type-2-diabetes-mellitus-4754https://curecurrent.com/trials/effects-of-cinnamon-supplementation-on-glucose-metabolism-in-patients-with-pre-diabetes-4755https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-study-of-single-and-repeated-doses-of-topical-gsk1278863-4756https://curecurrent.com/trials/collaborative-care-rehabilitation-after-dysvascular-amputation-4757https://curecurrent.com/trials/adaptive-device-for-insulin-pens-for-arthritic-patients-4758https://curecurrent.com/trials/esr-15-11293-saxa-dapa-safety-and-efficacy-study-4759https://curecurrent.com/trials/improved-cardiovascular-risk-reduction-to-enhance-rural-primary-care-4760https://curecurrent.com/trials/the-effects-of-nutrition-supplementation-and-education-on-the-healing-of-diabetic-foot-ulcer-dfu-4761https://curecurrent.com/trials/improving-glycemic-control-on-gms-a-quality-improvement-study-4762https://curecurrent.com/trials/metformin-and-cardiovascular-effectiveness-vs-sglt2-maces-4763https://curecurrent.com/trials/sleep-intervention-to-improve-glycemic-control-in-women-with-gestational-diabetes-4764https://curecurrent.com/trials/analysis-of-glycemic-control-in-type-1-diabetes-patients-using-hybrid-closed-loop-insulin-pump-therapy-medtronic-670g-4765https://curecurrent.com/trials/fit-one-a-trial-evaluating-the-effect-of-one-drop-and-fitbit-on-diabetes-and-pre-diabetes-outcomes-4766https://curecurrent.com/trials/model-predictive-control-mpc-artificial-pancreas-vs-sensor-augmented-pump-sap-predictive-low-glucose-suspend-plgs-with-d-4767https://curecurrent.com/trials/cooperation-of-insulin-and-glp-1-on-myocardial-glucose-uptake-4768https://curecurrent.com/trials/finding-the-patient-s-voice-diabetes-prevention-programs-4769https://curecurrent.com/trials/targeted-adherence-intervention-to-reach-glycemic-control-with-insulin-therapy-for-patients-with-diabetes-4770https://curecurrent.com/trials/naltrexone-bupropion-versus-placebo-bupropion-for-weight-loss-in-schizophrenia-4771https://curecurrent.com/trials/physical-activity-and-obesity-4772https://curecurrent.com/trials/ongoing-diabetes-self-management-support-in-church-based-settings-4773https://curecurrent.com/trials/reversing-type-1-diabetes-after-it-is-established-4774https://curecurrent.com/trials/comprehension-of-discharge-instructions-for-diabetes-therapy-and-hospital-readmission-4775https://curecurrent.com/trials/insulet-artificial-pancreas-free-living-ide3-4776https://curecurrent.com/trials/healthy-eating-physical-activity-and-glycemic-control-in-young-children-with-t1d-4777https://curecurrent.com/trials/phase-1-study-of-fg-3019-in-subjects-with-type-1-or-type-2-diabetes-mellitus-and-diabetic-nephropathy-4778https://curecurrent.com/trials/assessment-of-mealtime-bolus-insulin-behavior-4779https://curecurrent.com/trials/vascular-function-endothelin-and-inflammation-in-pre-diabetic-obesity-versus-lean-healthy-controls-4780https://curecurrent.com/trials/contribution-of-hyperinsulinemia-vs-hyperglycemia-to-insulin-resistance-in-type-1-diabetes-and-maturity-onset-diabetes-o-4781https://curecurrent.com/trials/diabetes-coaching-program-for-medicare-advantage-members-with-type-2-diabetes-impact-on-a1c-4782https://curecurrent.com/trials/measurement-of-eye-blood-flow-and-renal-function-in-healthy-and-diabetic-patients-4783https://curecurrent.com/trials/a-study-to-evaluate-bms-986036-in-obese-adults-with-type-2-diabetes-4784https://curecurrent.com/trials/dose-finding-of-semaglutide-administered-subcutaneously-once-daily-versus-placebo-and-liraglutide-in-subjects-with-type-4785https://curecurrent.com/trials/study-to-evaluate-the-effects-of-bms-813160-on-protein-loss-in-the-urine-of-subjects-with-type-2-diabetes-and-diabetic-k-4786https://curecurrent.com/trials/vitamin-d-and-calcium-homeostasis-for-prevention-of-type-2-diabetes-4787https://curecurrent.com/trials/exercise-detection-study-4788https://curecurrent.com/trials/project-powerfood-promoting-food-security-equity-and-health-4789https://curecurrent.com/trials/combined-liraglutide-and-metformin-therapy-in-women-with-previous-gestational-diabetes-mellitus-gdm-4790https://curecurrent.com/trials/effects-of-potato-resistant-starch-intake-on-insulin-sensitivity-related-metabolic-markers-and-satiety-4791https://curecurrent.com/trials/effects-of-almonds-on-insulin-sensitivity-in-prediabetes-4792https://curecurrent.com/trials/a-trial-comparing-cardiovascular-safety-of-insulin-degludec-versus-insulin-glargine-in-subjects-with-type-2-diabetes-at-4793https://curecurrent.com/trials/safety-and-efficacy-of-relamorelin-administered-to-participants-with-vomiting-symptoms-and-moderate-to-severe-diabetic-g-4794https://curecurrent.com/trials/lean-beef-consumption-and-insulin-sensitivity-in-men-and-women-with-risk-factors-for-diabetes-4795https://curecurrent.com/trials/effect-of-egg-consumption-on-cardiometabolic-health-in-prediabetic-subjects-4796https://curecurrent.com/trials/nutritional-regulation-of-wound-inflammation-part-ii-4797https://curecurrent.com/trials/safety-and-efficacy-study-of-albiglutide-liquid-drug-product-in-type-2-diabetes-mellitus-4798https://curecurrent.com/trials/insulin-glucose-glucagon-network-defining-a-type-1-diabetes-progression-index-4799https://curecurrent.com/trials/a-single-dose-study-of-pf-05161704-in-healthy-volunteers-4800https://curecurrent.com/trials/amitriptyline-in-treating-hypoglycemia-4801https://curecurrent.com/trials/botanical-oil-supplementation-in-diabetic-and-metabolic-syndrome-subjects-4802https://curecurrent.com/trials/predicting-development-of-diabetes-mellitus-in-patients-undergoing-allogeneic-stem-cell-transplant-4803https://curecurrent.com/trials/evaluation-of-a-ascensia-onyx-next-investigational-blood-glucose-monitoring-system-4804https://curecurrent.com/trials/islet-transplantation-in-type-1-diabetes-4805https://curecurrent.com/trials/liraglutide-effect-and-action-in-diabetes-evaluation-of-cardiovascular-outcome-results-4806https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-long-term-treatment-with-belviq-lorcaserin-hcl-on-the-incidence-of-major-adverse-cardi-4807https://curecurrent.com/trials/evaluating-the-user-performance-and-experience-of-nucleus-pen-vs-commercially-available-pen-needle-4808https://curecurrent.com/trials/gestational-diabetes-mellitus-trial-gdm-4809https://curecurrent.com/trials/the-feasibility-of-a-diet-and-exercise-intervention-in-diabetics-during-treatment-for-non-muscle-invasive-bladder-cancer-4810https://curecurrent.com/trials/extension-to-study-200952-to-evaluate-the-long-term-safety-tolerability-and-pharmacodynamics-of-albiglutide-liquid-drug-4811https://curecurrent.com/trials/diabetes-dietary-study-low-carbohydrate-and-low-fat-diets-in-type-2-diabetes-4812https://curecurrent.com/trials/technologically-enhanced-coaching-a-program-to-improve-diabetes-outcomes-4813https://curecurrent.com/trials/a-new-wizard-for-insulin-sensitivity-estimation-from-sap-a-randomized-controlled-trial-in-adolescents-with-t1d-4814https://curecurrent.com/trials/effect-of-bariatric-surgery-on-mechanisms-of-type-2-diabetes-4815https://curecurrent.com/trials/growth-hormone-feedback-to-insulin-like-growth-factor-i-igf-1-and-oral-glucose-tolerance-test-ogtt-4816https://curecurrent.com/trials/an-observational-pilot-study-to-develop-a-behavioral-economics-electronic-health-record-module-to-guide-the-care-of-olde-4817https://curecurrent.com/trials/non-healing-diabetic-foot-ulcers-dfu-treated-with-soc-with-or-without-neox-cord-1k-4818https://curecurrent.com/trials/trial-to-evaluate-cardiovascular-and-other-long-term-outcomes-with-semaglutide-in-subjects-with-type-2-diabetes-4819https://curecurrent.com/trials/enhancement-of-cerebral-vasoreactivity-and-cognition-by-intranasal-insulin-in-type-2-diabetes-4820https://curecurrent.com/trials/multi-center-site-controlled-trial-comparing-a-bioengineered-skin-substitute-to-a-human-skin-allograft-4821https://curecurrent.com/trials/digital-self-management-program-for-medicare-advantage-members-with-type-2-diabetes-impact-on-a1c-4822https://curecurrent.com/trials/statins-in-children-with-type-1-diabetes-and-hypercholesterolemia-4823https://curecurrent.com/trials/effect-of-cycloset-on-glycemic-control-when-added-to-glucagon-like-peptide-1-glp-1-analogue-therapy-4824https://curecurrent.com/trials/family-model-of-diabetes-self-management-education-in-the-marshallese-community-4825https://curecurrent.com/trials/exenatide-inpatient-trial-a-randomized-controlled-pilot-trial-on-the-safety-and-efficacy-of-exenatide-byetta-therapy-for-4826https://curecurrent.com/trials/changing-healthy-outcomes-in-clinic-environments-4827https://curecurrent.com/trials/hispanic-secondary-stroke-prevention-initiative-4828https://curecurrent.com/trials/assessing-home-food-environment-and-diabetes-self-management-among-adult-type-2-diabetes-patients-4829https://curecurrent.com/trials/the-va-diabetes-trial-follow-up-study-vadt-fs-4830https://curecurrent.com/trials/point-of-care-health-literacy-and-activation-information-to-improve-diabetes-care-4831https://curecurrent.com/trials/targeted-enteral-nutrient-delivery-a-prospective-randomized-study-4832https://curecurrent.com/trials/freestyle-libre-flash-glucose-monitoring-system-pediatric-accuracy-study-4833https://curecurrent.com/trials/effect-of-occupational-therapy-in-promoting-medication-adherence-4834https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-study-of-egt0001474-in-subjects-with-type-2-diabetes-4835https://curecurrent.com/trials/a-trial-investigating-the-efficacy-and-safety-of-insulin-degludec-in-children-and-adolescents-with-type-1-diabetes-melli-4836https://curecurrent.com/trials/efficacy-and-safety-of-semaglutide-once-weekly-versus-insulin-glargine-once-daily-as-add-on-to-metformin-with-or-without-4837https://curecurrent.com/trials/a-study-to-evaluate-the-safety-of-thr-149-in-subjects-with-diabetic-macular-edema-dme-4838https://curecurrent.com/trials/efficacy-and-safety-of-semaglutide-once-weekly-versus-exenatide-er-2-0-mg-once-weekly-as-add-on-to-1-2-oral-antidiabetic-4839https://curecurrent.com/trials/parent-mentors-to-improve-adherence-to-type-i-diabetes-care-regimen-in-adolescents-4840https://curecurrent.com/trials/efficacy-and-safety-of-faster-acting-insulin-aspart-compared-to-novorapid-both-in-combination-with-insulin-degludec-in-a-4841https://curecurrent.com/trials/efficacy-and-safety-of-semaglutide-once-weekly-versus-placebo-in-drug-na-ve-subjects-with-type-2-diabetes-4842https://curecurrent.com/trials/efficacy-and-safety-of-fiasp-in-a-basal-bolus-regimen-versus-basal-insulin-therapy-both-in-combination-with-metformin-in-4843https://curecurrent.com/trials/latinos-understanding-the-need-for-adherence-in-diabetes-4844https://curecurrent.com/trials/efficacy-and-safety-of-fiasp-compared-to-insulin-aspart-both-in-combination-with-insulin-detemir-in-adults-with-type-1-d-4845https://curecurrent.com/trials/a-trial-investigating-the-efficacy-and-safety-of-insulin-degludec-insulin-aspart-once-daily-plus-insulin-aspart-for-the-4846https://curecurrent.com/trials/dapagliflozin-and-metformin-alone-and-in-combination-in-overweight-obese-prior-gdm-women-4847https://curecurrent.com/trials/iomit-reducing-intentional-insulin-misuse-in-type-1-diabetes-4848https://curecurrent.com/trials/efficacy-and-safety-of-semaglutide-once-weekly-versus-placebo-as-add-on-to-basal-insulin-alone-or-basal-insulin-in-combi-4849https://curecurrent.com/trials/study-to-determine-the-safety-tolerability-and-pharmacokinetic-pk-profile-of-egt0001474-in-healthy-volunteers-4850https://curecurrent.com/trials/tele-pharmacy-intervention-to-improve-treatment-adherence-4851https://curecurrent.com/trials/effect-of-liraglutide-on-epicardial-fat-in-subjects-with-type-2-diabetes-4852https://curecurrent.com/trials/promotora-led-intervention-for-metabolic-and-mental-health-4853https://curecurrent.com/trials/efficacy-and-safety-of-faster-acting-insulin-aspart-compared-to-novorapid-both-in-combination-with-insulin-degludec-in-c-4854https://curecurrent.com/trials/a-study-of-an-automated-insulin-delivery-system-in-adult-participants-with-type-1-diabetes-4855https://curecurrent.com/trials/evaluation-of-an-ascensia-diabetes-care-blood-glucose-meter-and-app-system-4856https://curecurrent.com/trials/physiologic-insulin-therapy-for-the-management-of-hyperglycemia-in-the-hospital-4857https://curecurrent.com/trials/adolescent-self-care-and-knowledge-education-in-diabetes-improved-by-texting-4858https://curecurrent.com/trials/islet-cell-transplants-for-diabetes-4859https://curecurrent.com/trials/nutraceutical-citrulline-in-pregnancy-4860https://curecurrent.com/trials/vascular-impairment-in-type-ii-diabetes-mellitus-with-co-morbid-obstructive-sleep-apnea-4861https://curecurrent.com/trials/continuous-glucose-monitors-to-regulate-glucose-levels-in-type-2-diabetics-4862https://curecurrent.com/trials/avert-shock-arginine-vasopressin-during-the-early-resuscitation-of-traumatic-shock-4863https://curecurrent.com/trials/the-use-of-magnesium-to-improve-blood-pressure-cholesterol-and-glucose-control-4864https://curecurrent.com/trials/trial-to-evaluate-the-effect-of-aln-pcssc-treatment-on-low-density-lipoprotein-cholesterol-ldl-c-4865https://curecurrent.com/trials/dosing-study-of-ranibizumab-for-diabetic-retinal-and-macular-edema-4866https://curecurrent.com/trials/evaluation-of-vler-indiana-health-information-exchange-demonstration-project-4867https://curecurrent.com/trials/personalized-smartphone-assisted-coaching-system-to-improve-glucose-homeostasis-in-adults-with-prediabetes-main-study-4868https://curecurrent.com/trials/clinical-benefits-of-a-blood-glucose-monitoring-system-in-patients-with-type-2-diabetes-4869https://curecurrent.com/trials/study-of-st266-in-diabetic-subjects-with-deep-burns-managed-with-skin-grafts-4870https://curecurrent.com/trials/regulation-of-postprandial-nitric-oxide-bioavailability-and-vascular-function-by-dairy-milk-4871https://curecurrent.com/trials/peak-plantar-pressures-while-wearing-a-carbon-fiber-off-loading-orthoses-4872https://curecurrent.com/trials/a-trial-comparing-the-safety-and-efficacy-of-insulin-degludec-and-insulin-glargine-with-or-without-oads-in-subjects-with-4873https://curecurrent.com/trials/a-6-month-clinical-study-to-evaluate-the-effect-of-a-digital-disease-management-tool-in-patients-with-t2dm-4874https://curecurrent.com/trials/ursodiol-on-insulin-sensitivity-gastric-emptying-and-body-weight-with-type-2-diabetes-on-metformin-4875https://curecurrent.com/trials/cadence-and-intensity-in-adults-with-type-2-diabetes-4876https://curecurrent.com/trials/atrasentan-spermatogenesis-and-testicular-function-4877https://curecurrent.com/trials/real-world-glycemic-effectiveness-of-linagliptin-4878https://curecurrent.com/trials/cardioprotective-activities-of-whole-eggs-on-vascular-endothelial-function-in-prediabetic-adults-4879https://curecurrent.com/trials/building-a-healthy-temple-a-diabetes-self-management-support-program-in-hispanic-faith-community-settings-4880https://curecurrent.com/trials/role-of-methane-in-glycemic-control-4881https://curecurrent.com/trials/milk-protein-feeding-after-aerobic-exercise-in-older-adults-with-pre-diabetes-taking-the-biguanide-metformin-4882https://curecurrent.com/trials/effect-of-aged-garlic-extract-age-on-improving-coronary-atherosclerosis-in-people-with-type-2-diabetes-mellitus-4883https://curecurrent.com/trials/renal-effects-of-three-iodinated-contrast-media-cm-in-patients-at-risk-undergoing-coronary-angiography-4884https://curecurrent.com/trials/regulation-of-postprandial-nitric-oxide-bioavailability-and-vascular-function-by-dairy-fat-4885https://curecurrent.com/trials/the-vbloct2d-study-4886https://curecurrent.com/trials/a-study-of-an-automated-insulin-delivery-system-in-adult-participants-with-type-1-diabetes-mellitus-4887https://curecurrent.com/trials/yoga-as-a-complementary-therapy-for-adults-with-type-2-diabetes-4888https://curecurrent.com/trials/mitigation-of-type-2-diabetes-by-partial-ileal-bypass-4889https://curecurrent.com/trials/efficacy-study-of-diabetes-group-visits-4890https://curecurrent.com/trials/check-it-2-0-positive-psychology-intervention-for-adolescents-with-type-1-diabetes-4891https://curecurrent.com/trials/health-literacy-intervention-for-african-americans-with-diabetes-4892https://curecurrent.com/trials/gastrointestinal-sensorimotor-dysfunctions-in-diabetes-mellitus-4893https://curecurrent.com/trials/a-study-of-an-automated-insulin-delivery-system-in-adult-participants-with-type-1-diabetes-mellitus-during-meal-challeng-4894https://curecurrent.com/trials/anti-il-1-treatment-in-children-diabetic-keto-acidosis-dka-at-diagnosis-of-type-1-diabetes-4895https://curecurrent.com/trials/group-education-curriculum-for-older-teens-with-type-1-diabetes-4896https://curecurrent.com/trials/hybrid-closed-loop-pivotal-trial-in-type-1-diabetes-4897https://curecurrent.com/trials/type-1-diabetes-data-acquisition-and-transfer-adherence-study-4898https://curecurrent.com/trials/effect-of-hypoglycemia-on-sleep-4899https://curecurrent.com/trials/mhealth-titration-and-management-4900https://curecurrent.com/trials/pilam-go4health-weight-loss-program-to-prevent-heart-disease-4901https://curecurrent.com/trials/care-guides-in-the-primary-care-office-phase-ii-4902https://curecurrent.com/trials/targeting-inflammation-using-salsalate-in-type-2-diabetes-tinsal-t2d-4903https://curecurrent.com/trials/children-with-diabetes-at-risk-for-heart-disease-4904https://curecurrent.com/trials/fiber-mix-and-glycemic-response-4905https://curecurrent.com/trials/cardiovascular-and-renal-microvascular-outcome-study-with-linagliptin-in-patients-with-type-2-diabetes-mellitus-carmelin-4906https://curecurrent.com/trials/a-pilot-study-of-biomarkers-of-stress-in-youth-who-use-teens-connect-4907https://curecurrent.com/trials/multiple-ascending-dose-study-of-mk-5160-in-participants-with-type-1-and-type-2-diabetes-mellitus-mk-5160-002-4908https://curecurrent.com/trials/a-single-center-study-to-evaluate-the-efficacy-and-safety-of-etc-1002-in-subjects-with-type-2-diabetes-4909https://curecurrent.com/trials/insulin-lispro-6-days-versus-insulin-aspart-6-days-in-pump-use-4910https://curecurrent.com/trials/diabetes-and-gastric-by-pass-4911https://curecurrent.com/trials/promoting-the-universal-medication-schedule-via-mobile-and-ehr-technologies-4912https://curecurrent.com/trials/reducing-distress-and-improving-glycemic-control-in-adults-with-type-1-diabetes-4913https://curecurrent.com/trials/the-statin-choice-decision-aid-for-type-2-diabetes-patients-4914https://curecurrent.com/trials/a-study-to-assess-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-glwl-01-4915https://curecurrent.com/trials/a-euglycemic-insulin-clamp-study-in-type-1-diabetic-patients-with-oral-insulin-oramed-4916https://curecurrent.com/trials/evaluation-of-soy-protein-russian-tarragon-artemisia-dracunculus-l-4917https://curecurrent.com/trials/a-clinical-trial-to-prevent-new-onset-diabetes-after-transplantation-4918https://curecurrent.com/trials/efficacy-and-safety-of-liraglutide-versus-placebo-as-add-on-to-existing-diabetes-medication-in-subjects-with-type-2-diab-4919https://curecurrent.com/trials/hawaii-patient-reward-and-incentives-to-support-empowerment-4920https://curecurrent.com/trials/lipid-biomarkers-for-diabetic-heart-disease-4921https://curecurrent.com/trials/pharmacist-impact-on-pneumococcal-polysaccharide-vaccination-rates-in-patients-with-diabetes-in-a-supermarket-pharmacy-c-4922https://curecurrent.com/trials/moderate-alcohol-and-cardiovascular-health-trial-4923https://curecurrent.com/trials/a-phase-1-single-and-multiple-dose-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-me-4924https://curecurrent.com/trials/a-digital-health-tool-for-insulin-titration-dhit-individuals-with-type-2-diabetes-a-prospective-outcomes-study-with-a-re-4925https://curecurrent.com/trials/hyperbaric-oxygen-therapy-as-adjunctive-therapy-to-scaling-and-root-planing-in-the-management-of-periodontitis-in-patien-4926https://curecurrent.com/trials/check-it-positive-psychology-intervention-to-improve-adherence-in-adolescents-with-t1d-4927https://curecurrent.com/trials/preprandial-ghrelin-effect-4928https://curecurrent.com/trials/a-phase-2-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-pf-00489791-in-patients-with-type-2-diabetes-a-4929https://curecurrent.com/trials/an-educational-intervention-for-type-2-diabetes-patients-4930https://curecurrent.com/trials/a-study-of-ly2605541-versus-insulin-glargine-on-blood-sugar-4931https://curecurrent.com/trials/intraluminal-imaging-of-duodenal-layer-morphometry-in-patients-with-and-without-type-2-diabetes-4932https://curecurrent.com/trials/oklahoma-native-american-women-s-osteoporosis-screening-study-4933https://curecurrent.com/trials/a-study-to-evaluate-itca-650-for-the-treatment-of-type-2-diabetes-in-patients-with-high-baseline-hba1c-4934https://curecurrent.com/trials/comparison-of-efficacy-safety-and-tolerability-of-itca-650-to-empagliflozin-and-glimepiride-as-add-on-metformin-4935https://curecurrent.com/trials/providing-preventive-periodontal-treatment-to-hospitalized-patients-with-diabetes-4936https://curecurrent.com/trials/effect-of-albiglutide-when-added-to-standard-blood-glucose-lowering-therapies-on-major-cardiovascular-events-in-subjects-4937https://curecurrent.com/trials/pilot-study-of-between-visit-interaction-to-improve-glycemic-control-in-pregnancy-with-pre-existing-diabetes-4938https://curecurrent.com/trials/post-approval-study-of-the-ts-feature-with-the-530g-pump-system-supplemented-with-commercial-patient-data-4939https://curecurrent.com/trials/dapagliflozin-evaluation-in-patients-with-inadequately-controlled-type-1-diabetes-4940https://curecurrent.com/trials/photobiomodulation-ketogenic-diet-for-treatment-of-mid-periphery-retinal-disorders-for-alzheimer-s-disease-prevention-4941https://curecurrent.com/trials/connectedhearthealth-heart-failure-readmission-intervention-4942https://curecurrent.com/trials/adipose-tissue-function-after-pancreas-transplantation-4943https://curecurrent.com/trials/facilitating-improvements-in-kidney-health-using-a-smartphone-app-counseling-program-in-patients-with-diabetes-4944https://curecurrent.com/trials/a-study-of-how-insulin-peglispro-ly2605541-and-insulin-glargine-affect-the-breakdown-of-fat-and-sugar-in-type-1-diabetic-4945https://curecurrent.com/trials/improving-diabetes-control-through-peer-counseling-and-incentives-4946https://curecurrent.com/trials/overnight-closed-loop-study-in-u-s-4947https://curecurrent.com/trials/the-effects-of-passive-vibration-in-patients-with-diabetic-peripheral-neuropathy-4948https://curecurrent.com/trials/parents-of-young-adults-with-type-1-diabetes-an-exploratory-study-4949https://curecurrent.com/trials/ache-inhibitor-and-insulin-4950https://curecurrent.com/trials/multi-center-study-comparing-efficacy-and-safety-of-frequently-modified-insulin-therapy-4951https://curecurrent.com/trials/process-versus-outcomes-incentives-for-lipid-management-4952https://curecurrent.com/trials/safety-efficacy-study-of-subcutaneously-injected-prandial-insulins-compared-to-insulin-lispro-alone-in-participants-with-4953https://curecurrent.com/trials/a-randomized-controlled-trial-evaluating-one-drop-premium-with-afrezza-vs-one-drop-premium-alone-4954https://curecurrent.com/trials/the-virtual-visit-for-women-with-gestational-diabetes-4955https://curecurrent.com/trials/randomized-double-blind-2-way-crossover-study-of-csii-with-versus-without-pretreatment-with-human-hyaluronidase-4956https://curecurrent.com/trials/role-of-exenatide-in-type-1-diabetes-4957https://curecurrent.com/trials/pharmacokinetic-pk-pharmacodynamic-pd-and-safety-study-of-subcutaneously-administered-humalog-with-and-without-recombina-4958https://curecurrent.com/trials/phase-ii-pharmacokinetics-study-of-humalog-and-humulin-r-with-and-without-rhuph20-in-type-1-diabetes-mellitus-4959https://curecurrent.com/trials/study-to-evaluate-bacterial-activity-that-drives-the-progression-of-clinical-infection-4960https://curecurrent.com/trials/12-week-study-of-ds-8500a-in-subjects-with-type-2-diabetes-mellitus-on-metformin-4961https://curecurrent.com/trials/effect-of-melatonin-on-cardiometabolic-risk-full-4962https://curecurrent.com/trials/nushield-affinity-for-the-treatment-of-neuropathic-diabetic-foot-ulcers-4963https://curecurrent.com/trials/study-of-fibrogen-fg-3019-in-subjects-with-type-2-diabetes-mellitus-and-kidney-disease-on-acei-and-or-arb-therapy-4964https://curecurrent.com/trials/collaborative-care-for-depression-and-diabetic-retinopathy-in-african-americans-4965https://curecurrent.com/trials/study-of-dopamine-versus-vasopressin-for-treatment-of-low-blood-pressure-in-low-birth-weight-infants-4966https://curecurrent.com/trials/advancing-diabetes-management-in-adolescents-using-health-information-technology-4967https://curecurrent.com/trials/linagliptin-inpatient-trial-4968https://curecurrent.com/trials/dynamic-study-diabetes-nurse-case-management-and-motivational-interviewing-for-change-4969https://curecurrent.com/trials/a-study-of-an-automated-insulin-delivery-system-in-adult-participants-with-type-1-diabetes-mellitus-t1d-4970https://curecurrent.com/trials/the-use-of-alpha-lipoic-acid-for-the-treatment-and-prevention-of-diabetic-retinopathy-4971https://curecurrent.com/trials/biomarkers-in-exhaled-breath-of-glucose-fluctuation-in-type-1-diabetes-4972https://curecurrent.com/trials/analysis-for-nsaid-vs-corticosteroid-shoulder-injection-in-diabetic-patients-4973https://curecurrent.com/trials/effect-of-saxagliptin-on-epcs-as-a-cellular-biomarker-for-evaluating-endothelial-dysfunction-in-early-t2dm-patients-4974https://curecurrent.com/trials/chronic-cardiovascular-risk-outpatient-management-in-south-asians-using-digital-health-technology-4975https://curecurrent.com/trials/the-goodnews-lifestyle-enhancement-program-4976https://curecurrent.com/trials/dose-safety-hybrid-closed-loop-and-fully-automated-closed-loop-artificial-pancreas-device-in-crc-4977https://curecurrent.com/trials/the-effects-of-liraglutide-on-sudomotor-function-and-inflammation-in-type-2-diabetes-4978https://curecurrent.com/trials/connected-catheter-c2p-study-for-bladder-management-4979https://curecurrent.com/trials/randomized-controlled-clinical-trial-of-cinnamon-to-lower-hemoglobin-a1c-4980https://curecurrent.com/trials/pathobiology-of-remission-of-type-2-diabetes-4981https://curecurrent.com/trials/simultaneous-risk-factor-control-using-telehealth-to-slow-progression-of-diabetic-kidney-disease-stop-dkd-4982https://curecurrent.com/trials/chinese-diabetes-prevention-program-chinese-dpp-4983https://curecurrent.com/trials/men-together-making-a-difference-health-promotion-for-black-men-4984https://curecurrent.com/trials/continuous-glucose-monitoring-in-type-2-diabetes-mellitus-4985https://curecurrent.com/trials/lifestyle-intervention-program-for-women-with-gestational-diabetes-or-gestational-impaired-glucose-tolerance-4986https://curecurrent.com/trials/community-based-participatory-research-to-improve-health-and-quality-of-life-of-latino-youth-every-little-step-counts-4987https://curecurrent.com/trials/psychosocial-functioning-in-young-adults-with-type-1-diabetes-4988https://curecurrent.com/trials/a-study-of-continuous-subcutaneous-insulin-infusion-csii-pump-function-in-subjects-with-type-1-diabetes-with-recombinant-4989https://curecurrent.com/trials/tu-salud-your-health-randomized-control-study-in-patients-with-diabetes-using-a-mobile-app-4990https://curecurrent.com/trials/vasopressin-plasma-concentrations-in-patients-receiving-exogenous-vasopressin-infusion-for-septic-shock-4991https://curecurrent.com/trials/a-comparative-clinical-trial-of-the-tensortip-a-novel-non-invasive-device-for-measurement-blood-parameters-4992https://curecurrent.com/trials/annular-array-ultrasound-in-ophthalmology-4993https://curecurrent.com/trials/spinal-cord-stimulation-for-diabetic-polyneuropathy-4994https://curecurrent.com/trials/efficacy-and-safety-of-fiasp-compared-to-insulin-aspart-in-combination-with-insulin-glargine-and-metformin-in-adults-wit-4995https://curecurrent.com/trials/freestyle-libre-glucose-monitoring-system-in-pediatric-populations-4996https://curecurrent.com/trials/a-study-of-ly3025876-in-participants-with-diabetes-4997https://curecurrent.com/trials/treatment-of-diabetes-after-gastric-bypass-with-sitagliptin-4998https://curecurrent.com/trials/negative-pressure-wound-therapy-as-a-drug-delivery-system-adanpwt-4999https://curecurrent.com/trials/a-study-to-evaluate-pharmacokinetics-safety-and-efficacy-of-albiglutide-in-pediatric-subjects-with-type-2-diabetes-melli-5000